<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Interval brain imaging for adults with cerebral glioma - Thompson, G - 2019 | Cochrane Library</title> <meta content="Interval brain imaging for adults with cerebral glioma - Thompson, G - 2019 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013137.pub2/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Interval brain imaging for adults with cerebral glioma - Thompson, G - 2019 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013137.pub2/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD013137.pub2" name="dc.identifier" scheme="DOI"/> <meta content="Interval brain imaging for adults with cerebral glioma" name="citation_title"/> <meta content="Gerard Thompson&lt;sup&gt;a&lt;/sup&gt;" name="citation_author"/> <meta content="University of Edinburgh" name="citation_author_institution"/> <meta content="Theresa A Lawrie&lt;sup&gt;a&lt;/sup&gt;" name="citation_author"/> <meta content="The Evidence‐Based Medicine Consultancy Ltd" name="citation_author_institution"/> <meta content="tesslawrie@gmail.com" name="citation_author_email"/> <meta content="Ashleigh Kernohan" name="citation_author"/> <meta content="Newcastle University" name="citation_author_institution"/> <meta content="Michael D Jenkinson" name="citation_author"/> <meta content="Institute of Translational Medicine" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="12" name="citation_issue"/> <meta content="10.1002/14651858.CD013137.pub2" name="citation_doi"/> <meta content="2019" name="citation_date"/> <meta content="2019/12/24" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013137.pub2/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013137.pub2/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013137.pub2/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Brain Neoplasms [*diagnostic imaging, mortality, surgery]; Controlled Before‐After Studies; Glioma [*diagnostic imaging, mortality, surgery]; Magnetic Resonance Imaging [*methods]; Randomized Controlled Trials as Topic; Reoperation" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013137.pub2&amp;doi=10.1002/14651858.CD013137.pub2&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013137.pub2&amp;doi=10.1002/14651858.CD013137.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013137.pub2&amp;doi=10.1002/14651858.CD013137.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013137.pub2&amp;doi=10.1002/14651858.CD013137.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013137.pub2&amp;doi=10.1002/14651858.CD013137.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013137.pub2&amp;doi=10.1002/14651858.CD013137.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013137.pub2&amp;doi=10.1002/14651858.CD013137.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013137.pub2&amp;doi=10.1002/14651858.CD013137.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013137.pub2&amp;doi=10.1002/14651858.CD013137.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013137.pub2&amp;doi=10.1002/14651858.CD013137.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013137.pub2&amp;doi=10.1002/14651858.CD013137.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013137.pub2&amp;doi=10.1002/14651858.CD013137.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013137.pub2&amp;doi=10.1002/14651858.CD013137.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013137.pub2&amp;doi=10.1002/14651858.CD013137.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013137.pub2&amp;doi=10.1002/14651858.CD013137.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013137.pub2&amp;doi=10.1002/14651858.CD013137.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013137.pub2&amp;doi=10.1002/14651858.CD013137.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013137.pub2&amp;doi=10.1002/14651858.CD013137.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013137.pub2&amp;doi=10.1002/14651858.CD013137.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013137.pub2&amp;doi=10.1002/14651858.CD013137.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013137.pub2&amp;doi=10.1002/14651858.CD013137.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013137.pub2&amp;doi=10.1002/14651858.CD013137.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013137.pub2&amp;doi=10.1002/14651858.CD013137.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774054000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774081000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000"}};Liferay.authToken="6XSHdtL3";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD013137\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD013137\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013137\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD013137\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1559916434000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","zh_HANS","ms","fa"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD013137.pub2",title:"Interval brain imaging for adults with cerebral glioma",firstPublishedDate:"Dec 24, 2019 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Gynaecological, Neuro‐oncology and Orphan Cancer Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738735355000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=6XSHdtL3&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD013137.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD013137.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD013137.pub2/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD013137.pub2/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD013137.pub2%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD013137.pub2/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD013137.pub2/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD013137.pub2/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD013137.pub2/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD013137.PUB2" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;概要&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD013137.pub2/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD013137.PUB2" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD013137.pub2/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD013137.pub2/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>2921 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD013137.pub2" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013137.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013137.pub2/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013137.pub2/full#CD013137-abs-0003"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013137.pub2/full#CD013137-sec-0079"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013137.pub2/full#CD013137-sec-0022"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013137.pub2/full#CD013137-sec-0023"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013137.pub2/full#CD013137-sec-0027"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013137.pub2/full#CD013137-sec-0028"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013137.pub2/full#CD013137-sec-0056"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013137.pub2/full#CD013137-sec-0072"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD013137.pub2/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013137.pub2/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013137.pub2/appendices#CD013137-sec-0084"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013137.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013137.pub2/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD013137.pub2/media/CDSR/CD013137/table_n/CD013137StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD013137.pub2/media/CDSR/CD013137/table_n/CD013137StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013137.pub2/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013137.pub2/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013137.pub2/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD013137.pub2/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD013137.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD013137.pub2/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2019 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD013137.pub2/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Interval brain imaging for adults with cerebral glioma</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author custom-tooltip" title="Authors 1 &amp; 2 contributed equally to this work"><a href="/cdsr/doi/10.1002/14651858.CD013137.pub2/information#CD013137-cr-0002">Gerard Thompson</a><sup>a</sup></li> <li class="author custom-tooltip" title="Authors 1 &amp; 2 contributed equally to this work"><a href="/cdsr/doi/10.1002/14651858.CD013137.pub2/information#CD013137-cr-0003"><i class="icon corresponding-author fa fa-envelope"></i>Theresa A Lawrie</a><sup>a</sup></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD013137.pub2/information#CD013137-cr-0004">Ashleigh Kernohan</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD013137.pub2/information#CD013137-cr-0005">Michael D Jenkinson</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD013137.pub2/information/en#CD013137-sec-0103">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 24 December 2019 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD013137.pub2/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD013137.pub2">https://doi.org/10.1002/14651858.CD013137.pub2</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD013137-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD013137-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD013137-abs-0002">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD013137-abs-0008">فارسی</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD013137-abs-0005">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD013137-abs-0001" lang="en"> <section id="CD013137-sec-0001"> <h3 class="title" id="CD013137-sec-0001">Background</h3> <p>Clinical practice guidelines suggest that magnetic resonance imaging (MRI) of the brain should be performed at certain time points or intervals distant from diagnosis (interval or surveillance imaging) of cerebral glioma, to monitor or follow up the disease; it is not known, however, whether these imaging strategies lead to better outcomes among patients than triggered imaging in response to new or worsening symptoms. </p> </section> <section id="CD013137-sec-0002"> <h3 class="title" id="CD013137-sec-0002">Objectives</h3> <p>To determine the effect of different imaging strategies (in particular, pre‐specified interval or surveillance imaging, and symptomatic or triggered imaging) on health and economic outcomes for adults with glioma (grades 2 to 4) in the brain. </p> </section> <section id="CD013137-sec-0003"> <h3 class="title" id="CD013137-sec-0003">Search methods</h3> <p>The Cochrane Gynaecological, Neuro‐oncology and Orphan Cancers (CGNOC) Group Information Specialist searched the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE and Embase up to 18 June 2019 and the NHS Economic Evaluation Database (EED) up to December 2014 (database closure). </p> </section> <section id="CD013137-sec-0004"> <h3 class="title" id="CD013137-sec-0004">Selection criteria</h3> <p>We included randomised controlled trials, non‐randomised controlled trials, and controlled before‐after studies with concurrent comparison groups comparing the effect of different imaging strategies on survival and other health outcomes in adults with cerebral glioma; and full economic evaluations (cost‐effectiveness analyses, cost‐utility analyses and cost‐benefit analyses) conducted alongside any study design, and any model‐based economic evaluations on pre‐ and post‐treatment imaging in adults with cerebral glioma. </p> </section> <section id="CD013137-sec-0005"> <h3 class="title" id="CD013137-sec-0005">Data collection and analysis</h3> <p>We used standard Cochrane review methodology with two authors independently performing study selection and data collection, and resolving disagreements through discussion. We assessed the certainty of the evidence using the GRADE approach. </p> </section> <section id="CD013137-sec-0006"> <h3 class="title" id="CD013137-sec-0006">Main results</h3> <p>We included one retrospective, single‐institution study that compared post‐operative imaging within 48 hours (early post‐operative imaging) with no early post‐operative imaging among 125 people who had surgery for glioblastoma (GBM: World Health Organization (WHO) grade 4 glioma). Most patients in the study underwent maximal surgical resection followed by combined radiotherapy and temozolomide treatment. Although patient characteristics in the study arms were comparable, the study was at high risk of bias overall. </p> <p>Evidence from this study suggested little or no difference between early and no early post‐operative imaging with respect to overall survival (deaths) at one year after diagnosis of GBM (risk ratio (RR) 0.86, 95% confidence interval (CI) 0.61 to 1.21; 48% vs 55% died, respectively; very low certainty evidence) and little or no difference in overall survival (deaths) at two years after diagnosis of GBM (RR 1.06, 95% CI 0.91 to 1.25; 86% vs 81% died, respectively; very low certainty evidence). No other review outcomes were reported. </p> <p>We found no evidence on the effectiveness of other imaging schedules. In addition, we identified no relevant economic evaluations assessing the efficiency of the different imaging strategies. </p> </section> <section id="CD013137-sec-0007"> <h3 class="title" id="CD013137-sec-0007">Authors' conclusions</h3> <p>The effect of different imaging strategies on survival and other health outcomes remains largely unknown. Existing imaging schedules in glioma seem to be pragmatic rather than evidence‐based. The limited evidence suggesting that early post‐operative brain imaging among GBM patients who will receive combined chemoradiation treatment may make little or no difference to survival needs to be further researched, particularly as early post‐operative imaging also serves as a quality control measure that may lead to early re‐operation if residual tumour is identified. Mathematical modelling of a large glioma patient database could help to distinguish the optimal timing of surveillance imaging for different types of glioma, with stratification of patients facilitated by assessment of individual tumour growth rates, molecular biomarkers and other prognostic factors. In addition, paediatric glioma study designs could be used to inform future research of imaging strategies among adults with glioma. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD013137-abs-0003" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD013137-abs-0003">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD013137-abs-0004">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD013137-abs-0009">فارسی</a> </li> <li class="section-language"> <a class="" href="full/ms#CD013137-abs-0007">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD013137-abs-0006">简体中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD013137-abs-0003" lang="en"> <h3>Brain scans for people with cerebral gliomas</h3> <p><b><i>Background</i> </b> </p> <p>Gliomas are brain tumours arising from the supporting brain tissues. They are termed low grade (WHO 1 and 2) or high grade (WHO 3 and 4), depending on their cell activity and how aggressive the tumour is. Gliomas are diagnosed in 4 to 11 people for every 100,000 each year, more commonly in high‐income countries. Whilst low‐grade, slow‐growing gliomas may be watched before deciding the most appropriate treatment (active surveillance), most people with gliomas will eventually undergo surgery to safely remove as much of the tumour as possible. After surgery, other treatments such as radiation and chemotherapy might be suitable, depending on the tumour grade and other aspects. The standard treatment for grade 4 tumours, known as glioblastomas, is radiotherapy and an anti‐cancer medicine (temozolomide). </p> <p>In people with slow‐growing tumours, magnetic resonance imaging (MRI) scans are usually performed at regular intervals to check tumour growth before treatment. After surgery to remove gliomas of any grade, regular scans check how tumours are responding to added treatment and whether the disease is coming back. Scans are mostly performed at set timings rather than happening due to changes in a patient's condition. This is known as surveillance imaging. An MRI is often done within three days of high‐grade glioma surgery to check how much tumour has been removed. </p> <p>Instead of having regular scans, you could scan when someone experiences changes suggesting that the tumour has grown. This is known as symptomatic or triggered imaging. Brain scans can be expensive and regular scans when a person feels well may cause anxiety. Also, if a brain scan will not change treatment it might not be needed. We undertook this review because it is not known whether different timings of imaging have an impact on the time a person will survive after diagnosis. We also wanted to see which approach was better in identifying concerning tumour changes, and effects on quality of life, anxiety and depression. We also searched to see which approach would provide better value to the health service. </p> <p><b><i>How we conducted the review and what we found</i> </b> </p> <p>We looked for studies involving adults with gliomas that compared current practice of doing scans at specific time points with other approaches. We found only one study meeting our criteria. This was from a cancer centre in the USA, looking at glioblastoma patients (those with the most aggressive gliomas) who had been treated between 2006 and 2016. The study involved 125 people and split them into those scanned within two days of surgery (early scan) with those who were not. They showed that doing the early scan made no change to the chance of being alive at one and two years after diagnosis. This might have been because the early scans were not used to change treatments, which mainly were to receive standard radiotherapy and temozolomide, and we could not tell if the patients' surgeon(s) were different or had different approaches to care. We judged this suggestion of little change in survival time with or without early scanning to be very uncertain. The number of people included over 10 years was small, and the decision whether or not to have a scan after surgery was based on surgeon's choice. It was not clear whether the surgeon(s) involved or their approaches to care differed, nor whether a person's care might have been changed in light of early imaging. The other search did not find any studies looking at the value of different imaging approaches. </p> <p><b><i>Conclusions</i> </b> </p> <p>We still do not know whether doing scans regularly at specific times after glioma diagnosis changes how well patients do. The limited evidence, suggesting early scans after operations do not affect survival, is unreliable and more research is needed, especially as early scans may also help surgeons improve their practice, and decide whether to repeat the operation earlier than they might otherwise have chosen to do. </p> <p>The best timings and reasons for scanning brain gliomas in adults are not known. Lessons might be learned from studies involving children, and by looking at large collections of clinical trials. It is also important to study the potential costs and benefits of different strategies. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD013137-sec-0079" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD013137-sec-0079"></div> <h3 class="title" id="CD013137-sec-0080">Implications for practice</h3> <section id="CD013137-sec-0080"> <p>Current approaches to imaging gliomas are based on plausibility and pragmatism through expert consensus rather than a body of high‐level research evidence. It remains unknown whether identification of progression through surveillance imaging instead of symptomatic imaging improves glioma survival or other health outcomes. Limited evidence suggesting that early post‐operative brain imaging among GBM patients who receive combined chemoradiation treatment could make little or no difference to survival needs robust assessment through further research, particularly as early post‐operative imaging also serves as a quality control measure that may lead to early re‐operation if residual tumour is identified. </p> <p>We expect that as further evidence on prognostic indicators comes to light, it might be possible to stratify people with glioma to different imaging schedules based on assessment of tumour behaviour and other prognostic factors particular to each individual. A clear example of this would be the recognition of molecular high‐risk, histologically low‐grade glioma, which would be managed as per GBM. In the absence of good‐quality evidence on the effectiveness and optimal frequency of surveillance imaging, a multi‐disciplinary team approach and shared decision‐making is essential in the context of existing broad consensus recommendations. </p> </section> <h3 class="title" id="CD013137-sec-0081">Implications for research</h3> <section id="CD013137-sec-0081"> <p>There are efforts across neuro‐oncology to standardise or harmonise both the type and timing of imaging although, as described above, this is not based on any high‐quality evidence. Researching management of gliomas is challenging because it is an uncommon disease covering a variety of age groups and prognostic types, for some of whom the optimal treatment strategy remains uncertain. There is also the added challenge of a shifting diagnostic and prognostic landscape with recent additions of molecular characterisation which is expected to expand in the near future. Collaborative, multicentre studies are now considered essential to sufficiently power relevant clinical questions. There is also the philosophical challenge of investigating higher versus lower frequency imaging; particularly in the oncology sphere, where in general there is an evolution in management aimed at replacing or adding to regimens rather than removing from them. There are relevant precedents, however, including alterations to surveillance imaging practice, such as regular chest radiographs and bone scintigraphy in breast cancer having demonstrated a lack of value (<a href="./references#CD013137-bbs2-0070" title="LamDL , HoussamiM , LeeJM . Imaging surveillance after primary breast cancer treatment. AJR. American Journal of Roentgenology2017;208(3):676‐86. ">Lam 2017</a>), and the paediatric studies discussed above, which recommended a significant reduction in the follow‐up imaging schedule. It should be possible to prospectively determine a research paradigm into imaging schedules in glioma in the era of shared decision‐making. </p> <p>It would also be of potential value to retrospectively evaluate individual patient data from trials that have been conducted in the post‐Stupp regimen RANO era for GBM, given the natural jitter in timing of follow‐up (i.e. not every patient is imaged precisely at 3‐monthly intervals), missed or delayed imaging visits for a variety of reasons, and different imaging frequencies in trials (e.g. 2‐ versus 3‐monthly) that likely have used the Stupp regimen in their control arms. These data could be analysed to determine if there are any impacts on outcome of different imaging schedules. Challenges to this would include the exclusion of any trial participants if being imaged off schedule represents a protocol violation and avoiding selection bias of those eligible to enter trials. </p> <p>Advanced imaging techniques to identify true progression (and not pseudoprogression) and true response (not pseudoresponse) also require rigorous evaluation in the relevant clinical contexts. </p> <p>Other research questions for high‐grade gliomas are as follows.</p> <p> <ul id="CD013137-list-0021"> <li> <p>Based on clinicoradiological or molecular markers (or both), can high‐grade gliomas be stratified into different interval imaging schedules to rationalise the frequency of imaging visits? </p> </li> <li> <p>What is the impact of interval imaging frequency on time to progression during first line treatment? </p> </li> <li> <p>How does interval imaging affect the entry to second line trials?</p> </li> <li> <p>Does the frequency of interval imaging influence overall survival?</p> </li> <li> <p>What are the cost effectiveness and diagnostic performance of additional imaging (e.g. MRS/perfusion/permeability MRI/PET) to determine response to treatment when progression is suspected in order to minimise repeated standard MRI during the current period of diagnostic uncertainty? </p> </li> </ul> </p> <p>Other research questions for low‐grade gliomas are as follows.</p> <p> <ul id="CD013137-list-0022"> <li> <p>Based on clinicoradiological or molecular markers (or both), can low‐grade gliomas be stratified into different interval imaging schedules to rationalise the frequency of imaging visits (e.g. IDH mutation status from 2HG spectroscopy)? </p> </li> <li> <p>Does interval imaging lead to earlier detection of progression and malignant transformation?</p> </li> <li> <p>Does interval imaging influence overall survival?</p> </li> <li> <p>What are the cost effectiveness and diagnostic performance of additional imaging (e.g. MRS/perfusion/permeability MRI/PET) to stratify patients into different prognostic groups requiring different imaging schedules? </p> </li> </ul> </p> <p>To improve decision‐making and promote good practice and external validity, protocols of future studies on imaging should adhere to prevailing guidance (e.g. CONSORT, QUADAS and STARD) to ensure the quality of the study, and should include economic and psychosocial outcomes whenever possible, in this era of shared decision‐making. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD013137-sec-0022" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD013137-sec-0022"></div> <div class="table" id="CD013137-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span><span class="table-title"></span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Early post‐operative MRI compared with no early post‐operative MRI for glioblastoma</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Patient or population:</b> adults with glioblastoma </p> <p><b>Settings:</b> tertiary care </p> <p><b>Intervention:</b> early post‐operative MRI (within 48 hours of tumour resection) </p> <p><b>Comparison:</b> no early post‐operative MRI </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>No early MRI</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Early MRI</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Overall survival (deaths at 1 year)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>554 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>476 per 1000</b><br/> (338 to 670) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(RR 0.86, 95% CI 0.61 to 1.21)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>125 (1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>very low<sup>1</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Overall survival (deaths at 2 years)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>804 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>852 per 1000</b><br/> (732 to 1000) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(RR 1.06, 95% CI 0.91 to 1.25)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>125 (1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>very low<sup>1</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Progression free survival</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="5" rowspan="1" valign=""> <p>no evidence</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Anxiety</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="5" rowspan="1" valign=""> <p>no evidence</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Quality of life</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="5" rowspan="1" valign=""> <p>no evidence</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> is the risk in the control group of the included study. The <b>corresponding risk</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High certainty:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate certainty:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low certainty:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low certainty:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>1</sup>Downgraded for risk of bias, as the patients in this study received the interventions based on surgeons' preferences and discretion </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD013137-sec-0023" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD013137-sec-0023"></div> <section id="CD013137-sec-0024"> <h3 class="title" id="CD013137-sec-0024">Description of the condition</h3> <p>Brain and other central nervous system (CNS) tumours are less common than many other cancers, accounting for around 1.9% of new cancer diagnoses annually and approximately 2.3% or 189,382 deaths worldwide in 2012 (<a href="./references#CD013137-bbs2-0066" title="International Agency for Research on Cancer. GLOBOCAN 2012: Estimated cancer incidence, mortality and prevalence worldwide in 2012. globocan.iarc.fr/Pages/fact_sheets_cancer.aspx (accessed 14 July 2016). ">GLOBOCAN 2012</a>). In terms of years of potential life lost (YPLL), in the USA malignant brain and other CNS tumours have the greatest impact of any cancer in adults, a reflection of their age of onset and the comparatively short survival time of some of the most common types (<a href="./references#CD013137-bbs2-0083" title="RouseC , GittlemanH , OstromQT , KruchkoC , Barnholtz‐SloanJS . Years of potential life lost for brain and CNS tumors relative to other cancers in adults in the United States, 2010. Neuro‐oncologyJanuary 2016;18(1):70‐7. [DOI: doi.org/10.1093/neuonc/nov249] ">Rouse 2016</a>). Gliomas are brain tumours that are believed to arise from progenitor glial lineage cells derived from neural stem cells (although this is still a matter of debate). They occur at an annual incidence of four to 11 people per 100,000 and are more frequent in high‐income, industrialised countries (<a href="./references#CD013137-bbs2-0079" title="OhgakiH . Epidemiology of brain tumours. In: VermaM editor(s). Methods of Molecular Biology, Cancer Epidemiology. Vol. 472, Totowa, NJ: Humana Press, 2009:323‐42. ">Ohgaki 2009</a>). Gliomas are graded 1 to 4 by the World Health Organization (WHO), according to their malignancy or malignant potential. The 2007 WHO classification system (<a href="./references#CD013137-bbs2-0072" title="LouisDN , OhgakiH , WiestlerOD , CaveneeWK , BurgerPC , JouvetA , et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathologica2007;114(2):97‐109. ">Louis 2007</a>), used in completed clinical studies since 2007, graded gliomas based on histological characteristics only. However in the 2016 WHO classification system, which is likely to be used in future studies, grading for the first time depends on both histological and molecular features, for example isocitrate dehydrogenase (IDH) status, chromosome 1p/19q co‐deletions, and other genetic parameters (<a href="./references#CD013137-bbs2-0073" title="LouisDN , PerryA , ReifenbergerG , vonDeimlingA , Figarella‐BrangerD , CaveneeWK , et al. The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathologica2016;131(6):803‐20. ">Louis 2016</a>). Molecular characterisation is now the default assessment where available, and supersedes the histological phenotype. Using the 2007 WHO classification, gliomas graded 1 and 2 are referred to as low‐grade gliomas: these included pilocytic astrocytomas (grade 1) which represent a distinct clinical entity with low malignant potential; and diffuse astrocytomas, oligodendrogliomas and mixed oligoastrocytomas (grade 2). High‐grade gliomas included anaplastic astrocytomas, anaplastic oligodendrogliomas (grade 3) and glioblastoma multiforme (GBM; grade 4). The 2016 classification separates pilocytic astrocytoma into "other astrocytic tumours" and it is the category of "diffuse astrocytic and oligodendroglial tumours" comprising grades 2 to 4 that are the focus of this review. As of 2016, true mixed oligoastrocytomas are now exceedingly rare, since detection of both canonical molecular signatures is required within the same tumour. Such changes are indicative of the challenges faced in interpreting previous studies in glioma in the current clinical context. While in the literature malignant transformation rates vary between approximately one in four to three in four, there is a significant risk of malignant transformation of low‐grade to high‐grade glioma and the potential for, and timing of, malignant transformation is not well understood. </p> <p>Grades correspond to prognosis. Grade 1 has a good prognosis and can often be cured with surgery alone; grade 2 gliomas have a median survival of five to fifteen years; anaplastic astrocytoma (grade 3) between two and five years; whereas grade 4 has the poorest prognosis, with a median survival of one to two years in the era of safe maximal resection and temozolomide chemoradiotherapy (<a href="./references#CD013137-bbs2-0072" title="LouisDN , OhgakiH , WiestlerOD , CaveneeWK , BurgerPC , JouvetA , et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathologica2007;114(2):97‐109. ">Louis 2007</a>). Even in the molecular era, therefore, tumour grade is a key factor in deciding how to treat gliomas. It also plays a role in determining the timing and frequency of radiologic follow‐up. It is increasingly recognised, however, that molecular characteristics also play a role, with 1p/19q co‐deleted IDH mutant oligodendrogliomas having a more favourable prognosis than 1p/19q intact IDH mutant diffuse astrocytomas, which in turn demonstrate longer survival than IDH‐wildtype diffuse astrocytomas. It is expected that further molecular characterisation of the last group will officially enter WHO classification in a future update, identifying those with GBM‐like markers, which can be managed in a similar way to high‐grade glioma despite the traditional histological appearance of low‐grade glioma. It is currently unclear how these molecular features will dovetail with traditional 'high risk' stratification of low‐grade glioma (e.g. <a href="./references#CD013137-bbs2-0080" title="PignattiF , Van denBentM , CurranD , DebruyneC , SylvesterR , TherasseP , et al. Prognostic factors for survival in adult patients with cerebral low‐grade glioma. Journal of Clinical Oncology2002;20(8):2076‐84. ">Pignatti 2002</a>), such as aged older than 40 years and achieving less than gross total resection. This evolving clinical and molecular risk stratification will have implications for future guidelines and research in how gliomas are treated and imaged. </p> </section> <section id="CD013137-sec-0025"> <h3 class="title" id="CD013137-sec-0025">Description of the intervention</h3> <p>Magnetic resonance imaging (MRI) or computed tomography (CT) of the brain is key to the diagnosis of a glioma. MRI is the preferred technique as it has superior soft tissue resolution and gives a better definition of tumour extent (<a href="./references#CD013137-bbs2-0075" title="National Comprehensive Cancer Network. NCCN Guidelines version 1. 2018. Central Nervous System Cancers. www.nccn.org/store/login/login.aspx?ReturnURL=https://www.nccn.org/professionals/physician_gls/pdf/cns.pdf (accessed 12 April 2018). ">NCCN 2018</a>; <a href="./references#CD013137-bbs2-0076" title="National Cancer Institute. Adult central nervous system tumors treatment (PDQ). www.cancer.gov/types/brain/hp/adult‐brain‐treatment‐pdq (accessed 20 December 2017). ">NCI 2017</a>; <a href="./references#CD013137-bbs2-0077" title="National Institute for Health and Clinical Excellence. Improving outcomes for people with brain and other CNS tumours. www.nice.org.uk/guidance/csg10/resources/improving‐outcomes‐for‐people‐with‐brain‐and‐other‐central‐nervous‐system‐tumours‐update‐pdf‐27841361437 (accessed 29 November 2017). ">NICE 2006</a>). These imaging techniques can, however, be challenging to interpret when distinguishing the type of tumour and grade, or occasionally when differentiating tumours from inflammatory or ischaemic lesions (e.g. following a stroke or radiation). This is particularly the case during follow‐up of treated gliomas where the most commonly used criterion of enlarging contrast‐enhancing lesions can be non‐specific and is also seen with treatment‐related effects such as pseudoprogression or radiation necrosis. Other imaging techniques, such as magnetic resonance spectroscopy (MRS), MR perfusion imaging, single photon emission computed tomography (SPECT) and positron emission photometry (PET), can be used to provide additional information prior to surgery to improve the accuracy of histopathological examination and provide increased specificity during follow‐up, although variation in training, performance, and availability of these techniques limits widespread use (<a href="./references#CD013137-bbs2-0075" title="National Comprehensive Cancer Network. NCCN Guidelines version 1. 2018. Central Nervous System Cancers. www.nccn.org/store/login/login.aspx?ReturnURL=https://www.nccn.org/professionals/physician_gls/pdf/cns.pdf (accessed 12 April 2018). ">NCCN 2018</a>; <a href="./references#CD013137-bbs2-0078" title="National Institute for Health and Clinical Excellence. Brain tumours (primary) and brain metastases in adults. www.nice.org.uk/guidance/ng99. NICE, (accessed 08 August 2018). ">NICE 2018</a>). </p> <p>In addition to primary diagnosis, brain imaging is an integral part of management and follow‐up of glioma and informs treatment decisions in the period immediately after diagnosis. After surgery, MRI has been shown to more accurately identify the extent of residual tumour — an important prognostic factor — than the neurosurgeon's estimation (<a href="./references#CD013137-bbs2-0003" title="AlbertFK , ForstingM , SartorK , AdamsHP , KunzeS . Early postoperative magnetic resonance imaging after resection of malignant glioma: objective evaluation of residual tumor and its influence on regrowth and prognosis. Neurosurgery1994;34(1):45‐60. ">Albert 1994</a>). The National Comprehensive Cancer Network (NCCN) guidelines recommends post‐operative brain MRI within 24 to 72 hours of glioma surgery for this purpose (<a href="./references#CD013137-bbs2-0075" title="National Comprehensive Cancer Network. NCCN Guidelines version 1. 2018. Central Nervous System Cancers. www.nccn.org/store/login/login.aspx?ReturnURL=https://www.nccn.org/professionals/physician_gls/pdf/cns.pdf (accessed 12 April 2018). ">NCCN 2018</a>). Imaging is also used universally to assess the tumour response among people actively receiving treatment and, in clinical studies of glioma treatment, imaging before the start of adjuvant therapy is common practice, which can serve as the baseline for detecting tumour progression (e.g. <a href="./references#CD013137-bbs2-0074" title="MalmströmA , PoulsenHS , GrønbergBH , StragliottoG , HansenS , AsklundT , et al. Postoperative neoadjuvant temozolomide before radiotherapy versus standard radiotherapy in patients 60 years or younger with anaplastic astrocytoma or glioblastoma: a randomized trial. Acta Oncologica2017;56(12):1776‐85. ">Malmström 2017</a>; <a href="./references#CD013137-bbs2-0093" title="WickW , PlattenM , MeisnerC , FelsbergJ , TabatabaiG , SimonM , et al. Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA‐08 randomised, phase 3 trial. Lancet Oncology2012;13(7):707‐15. ">Wick 2012</a>). In a study of bevacizumab for glioblastoma, performing a follow‐up MRI from as early as four weeks after starting treatment has been reported to be an accurate predictor of both treatment response and survival (<a href="./references#CD013137-bbs2-0015" title="FieldKM , PhalPM , FittG , GohC , NowakAK , RosenthalMA , et al. The role of early magnetic resonance imaging in predicting survival on Bevacizumab for recurrent glioblastoma: results from a prospective clinical trial (CABARET). Cancer2017;123(18):3576‐82. ">Field 2017</a>). </p> <p>Outside the immediate treatment period, people with glioma will also be offered imaging at regular intervals. Interval imaging, sometimes referred to as surveillance imaging, refers to imaging at defined future time points as requested by the clinical team, for monitoring tumour appearance. Outside periods of treatment, this is referred to as active surveillance. It is not known at that specific time point in the future whether the person affected will be less symptomatic, the same (i.e. stable), or be more symptomatic at the imaging visit. The imaging is not, therefore, based on a clinical deterioration of the person’s symptoms and signs. An alternative approach to interval imaging would be to arrange imaging when a person, carer, or clinician notes a deterioration in signs or symptoms (or both); this is called symptomatic or triggered imaging. Current practice represents a combination of these, with surveillance imaging as the default, and triggered imaging when a significant clinical change is encountered between planned imaging visits. </p> <p>There are several scenarios in which interval imaging is used among people with a glioma. Before surgical biopsy or treatment among those with a suspected low‐grade glioma, interval imaging might be performed to ensure that the actual growth of the tumour is not faster than that expected from the anticipated grade. It might also be considered for lesions with radiological features of a low‐grade tumour that do not necessitate immediate treatment, for example an optic pathway glioma (<a href="./references#CD013137-bbs2-0078" title="National Institute for Health and Clinical Excellence. Brain tumours (primary) and brain metastases in adults. www.nice.org.uk/guidance/ng99. NICE, (accessed 08 August 2018). ">NICE 2018</a>). After treatment, interval imaging is usually performed for both low‐grade and high‐grade gliomas to check for any interval tumour growth and to determine whether treatment has been successful at slowing or halting growth. The NCCN recommends MRI follow‐up of low‐grade gliomas every three to six months for five years, then at least annually thereafter; whereas for GBM, an MRI two to six weeks after radiotherapy, then every two to four months for three years, then every six months indefinitely, is recommended (<a href="./references#CD013137-bbs2-0075" title="National Comprehensive Cancer Network. NCCN Guidelines version 1. 2018. Central Nervous System Cancers. www.nccn.org/store/login/login.aspx?ReturnURL=https://www.nccn.org/professionals/physician_gls/pdf/cns.pdf (accessed 12 April 2018). ">NCCN 2018</a>). Suggested imaging intervals in National Institute for Health and Clinical Excellence (NICE) guidance are slightly longer (e.g. for GBM the suggested intervals are three to six months up to two years after treatment, then six to 12 months up to three years, then annually indefinitely (<a href="#CD013137-tbl-0002">Table 1</a>)). In general, though, for both low‐grade and high‐grade gliomas, interval duration increases over time from diagnosis and treatment. </p> <div class="table" id="CD013137-tbl-0002"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">National Institute for Health and Clinical Excellence (NICE) guidance on interval imaging</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Tumour grade</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Years after end of treatment</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>0 to 1</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>1 to 2</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>2 to 3</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>3 to 4</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>5 to 10</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>&gt; 10 (for the rest of life)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Grade 1</p> </td> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p>Scan at 12 months, then:</p> <p> <ul id="CD013137-list-0001"> <li> <p>consider discharge if no tumour visible on imaging unless completely resected pilocytic astrocytoma </p> </li> <li> <p>consider ongoing imaging at increasing intervals for 15 years for completely resected pilocytic astrocytoma </p> </li> <li> <p>consider if ongoing imaging is needed at a rate of once every 1 to 3 years for the rest of the person's life if the tumour is visible on imaging </p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Grade II 1p/19q non‐codeleted, IDH mutated</p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="3" valign="top"> <p>Scan at 3 months, then every 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="3" valign="top"> <p>Annually</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>Every 1 to 2 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>Consider ongoing imaging every 1 to 2 years</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Grade II 1p/19q codeleted</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Grade III 1p/19q codeleted</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Grade II IDH wildtype</p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="3" valign="top"> <p>Every 3 to</p> <p>6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="3" valign="top"> <p>Every 6 to</p> <p>12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>Annually</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>Consider ongoing imaging</p> <p>every 1 to 2 years</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Grade III 1p/19q non‐codeleted</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Grade IV (glioblastoma)</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>From <a href="./references#CD013137-bbs2-0078" title="National Institute for Health and Clinical Excellence. Brain tumours (primary) and brain metastases in adults. www.nice.org.uk/guidance/ng99. NICE, (accessed 08 August 2018). ">NICE 2018</a> (p17) Table 3: Possible regular clinical review schedule for people with glioma depending on grade of tumour </p> </div> </div> <p>SPECT and PET can also be helpful in the post‐treatment scenario to distinguish between tumour recurrence and treatment effects such as pseudoprogression and radiation necrosis (<a href="./references#CD013137-bbs2-0075" title="National Comprehensive Cancer Network. NCCN Guidelines version 1. 2018. Central Nervous System Cancers. www.nccn.org/store/login/login.aspx?ReturnURL=https://www.nccn.org/professionals/physician_gls/pdf/cns.pdf (accessed 12 April 2018). ">NCCN 2018</a>; <a href="./references#CD013137-bbs2-0076" title="National Cancer Institute. Adult central nervous system tumors treatment (PDQ). www.cancer.gov/types/brain/hp/adult‐brain‐treatment‐pdq (accessed 20 December 2017). ">NCI 2017</a>). This is an important role of imaging, since treatment‐related effects can be symptomatic, and either neutral (radiation necrosis) or favourable (pseudoprogression) when deciding on whether to maintain or change treatment. </p> </section> <section id="CD013137-sec-0026"> <h3 class="title" id="CD013137-sec-0026">Why it is important to do this review</h3> <p>To our knowledge, there are no existing systematic reviews of this topic. The relative benefits of surveillance imaging, if any, over other imaging approaches among people with glioma are currently not known. In addition, whilst clinical guidelines recommend routine MRI follow‐up or active monitoring, the optimal frequency of routine active monitoring has not been rigorously established. In existing clinical practice guidelines, it is recommended that the frequency of routine active monitoring decreases with time (<a href="./references#CD013137-bbs2-0075" title="National Comprehensive Cancer Network. NCCN Guidelines version 1. 2018. Central Nervous System Cancers. www.nccn.org/store/login/login.aspx?ReturnURL=https://www.nccn.org/professionals/physician_gls/pdf/cns.pdf (accessed 12 April 2018). ">NCCN 2018</a>; <a href="./references#CD013137-bbs2-0078" title="National Institute for Health and Clinical Excellence. Brain tumours (primary) and brain metastases in adults. www.nice.org.uk/guidance/ng99. NICE, (accessed 08 August 2018). ">NICE 2018</a>; <a href="./references#CD013137-bbs2-0086" title="Sepulveda‐SanchezJM , Munoz LangaJ , ArraezMA , FusterJ , Hernandez LainA , ReynesG , et al. SEONM clinical guideline of diagnosis and management of low‐grade glioma. Clinical &amp; Translational Oncology2017;epub:ahead of print. ">SEOM 2017</a>). However, since low‐grade glioma can present at any time during a natural history that might span over a decade, and the risk and timing of recurrence is unpredictable, frequent imaging early on might be unnecessary. </p> <p>Diagnostic uncertainties raised by brain imaging performed within the first three to six months due to treatment, such as true tumour progression versus pseudoprogression, might increase patient and clinician anxiety during this monitoring period, and negatively affect quality of life. In addition, potential health risks from repeat gadolinium administration has come under scrutiny recently, especially in people with longer‐term survival. Brain imaging is potentially costly, both for the health system and the individual and, while performing it routinely has not been robustly assessed from a health economic perspective, there are also limited data on the psychological impact experienced by patients and carers during treatment from repeated cycles of imaging and uncertainty while waiting on the result. </p> <p>Surveillance imaging was established as a follow‐up strategy early in the development of readily available non‐invasive imaging investigation, based on expert consensus. This basis has become questionable, since this expert opinion was derived from experience gained during the 'pre‐molecular' era when recent standards of care for glioma treatment were not yet available or established. The aim of this review, therefore, is to systematically evaluate the evidence for different imaging strategies to inform clinical practice guidelines and research agendas. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD013137-sec-0027" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD013137-sec-0027"></div> <p>To determine the effect of different imaging strategies (in particular, pre‐specified interval or surveillance imaging, and symptomatic or triggered imaging) on health and economic outcomes for adults with glioma (grades 2 to 4) in the brain. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD013137-sec-0028" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD013137-sec-0028"></div> <section id="CD013137-sec-0029"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD013137-sec-0030"> <h4 class="title">Types of studies</h4> <p>Randomised controlled trials (RCTs), non‐randomised controlled trials (NRCTs), and controlled before‐after studies (CBAS) with concurrent comparison groups. </p> <p>Full economic evaluations (cost‐effectiveness analyses, cost‐utility analyses and cost‐benefit analyses), conducted alongside any study design and any model‐based economic evaluations. </p> </section> <section id="CD013137-sec-0031"> <h4 class="title">Types of participants</h4> <p>Adults with a histologically confirmed diagnosis of cerebral glioma or suspected low‐grade infiltrating glioma on imaging. Given the known biological differences between adult and childhood gliomas, in addition to the different logistic challenges and economic aspects of imaging adult and paediatric populations, this review addresses adults with glioma. </p> </section> <section id="CD013137-sec-0032"> <h4 class="title">Types of interventions</h4> <p>Pre‐ or post‐treatment brain imaging, including MRI and other types of imaging, performed at regular intervals (interval or surveillance imaging) compared with pre‐ or post‐treatment brain imaging performed upon the development of new or worsening symptoms (symptomatic or triggered imaging) or other imaging schedules, such as hybrids, with a defined surveillance hiatus. </p> </section> <section id="CD013137-sec-0033"> <h4 class="title">Types of outcome measures</h4> <section id="CD013137-sec-0034"> <h5 class="title">Primary outcomes</h5> <p> <ul id="CD013137-list-0002"> <li> <p>Overall survival (as time‐to‐event or dichotomous outcomes or both)</p> </li> </ul> </p> </section> <section id="CD013137-sec-0035"> <h5 class="title">Secondary outcomes</h5> <p> <ul id="CD013137-list-0003"> <li> <p>Progression‐free survival (as time‐to‐event or dichotomous outcomes or both)</p> </li> <li> <p>Health‐related quality of life measured by a standardised instrument, such as the European Organisation for Research and Treatment of Cancer (EORTC) QLQ‐C30 or QLQ‐BN20 (specific for brain cancer), or the Functional Assessment of Cancer Therapy scale (FACT)‐G (general) or FACT‐Br (specific for brain cancer) </p> </li> <li> <p>Anxiety, measured by a standardised instrument, such as the Hospital Anxiety and Depression Scale (HADS) </p> </li> <li> <p>Depression, measured by a standardised instrument, such as HADS and the Beck Depression Inventory (BDI) </p> </li> <li> <p>Economic data (cost, cost effectiveness, cost utility and cost benefits)</p> </li> </ul> </p> </section> </section> </section> <section id="CD013137-sec-0036"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD013137-sec-0037"> <h4 class="title">Electronic searches</h4> <p>The Cochrane Gynaecological, Neuro‐oncology and Orphan Cancer (CGNOC) Information Specialist searched the following databases on 26 April 2018 and topped up the search for us on the 18 June 2019. </p> <p> <ul id="CD013137-list-0004"> <li> <p>For intervention studies</p> <ul id="CD013137-list-0005"> <li> <p>Cochrane Central Register of Controlled Trials (CENTRAL), in the Cochrane Library;</p> </li> <li> <p>MEDLINE Ovid (from 1946 onwards);</p> </li> <li> <p>Embase Ovid (from 1980 onwards).</p> </li> </ul> </li> </ul> <ul id="CD013137-list-0006"> <li> <p>For economic evidence</p> <ul id="CD013137-list-0007"> <li> <p>MEDLINE Ovid (from 2015);</p> </li> <li> <p>Embase Ovid (from 2015);</p> </li> <li> <p>NHS Economic Evaluation Database (EED).</p> </li> </ul> </li> </ul> </p> <p>The EED database was searched up to the end of December 2014 (when the last records were added to that database) and MEDLINE and Embase from 1 January 2015, as NHS EED already included comprehensive searches of these databases prior to 2015. We also considered relevant grey literature, such as health technology assessments, reports and working papers, for inclusion. </p> <p>Please refer to <a href="./appendices#CD013137-sec-0085">Appendix 1</a> for draft MEDLINE search strategies. We did not apply language restrictions to any of the searches. </p> </section> <section id="CD013137-sec-0038"> <h4 class="title">Searching other resources</h4> <p>We searched the following for ongoing studies.</p> <p> <ul id="CD013137-list-0008"> <li> <p>ClinicalTrials.gov (<a href="http://clinicaltrials.gov/" target="_blank">clinicaltrials.gov</a>) </p> </li> <li> <p>International Clinical Trials Registry Platform (ICTRP) (<a href="http://apps.who.int/trialsearch" target="_blank">apps.who.int/trialsearch</a>) </p> </li> </ul> </p> <p>We used the 'related articles' feature of PubMed and handsearched the reference lists of included studies to identify newly published articles and additional studies of relevance. If through these searches we had identified any ongoing studies that had not been published, we planned to approach the principal investigators to ask for an update on the study status and any available relevant data. </p> </section> </section> <section id="CD013137-sec-0039"> <h3 class="title" id="CD013137-sec-0039">Data collection and analysis</h3> <section id="CD013137-sec-0040"> <h4 class="title">Selection of studies</h4> <p>The CGNOC Information Specialist downloaded all titles and abstracts retrieved by electronic searching for intervention studies to Endnote® and removed duplicates. Two review authors (GT and TL) independently screened the remaining records on title and abstract. For potentially eligible records, we obtained copies of the full texts and independently assessed them for eligibility. The two review authors resolved any disagreements by discussion. We used <a href="./references#CD013137-bbs2-0062" title="Veritas Health Innovation. Covidence. Melbourne, Australia: Veritas Health Innovation. ">Covidence</a> to facilitate this study selection process and documented reasons for exclusion accordingly. </p> <p>In our search for economic evidence, two review authors independently screened for eligible studies using the same methods as above. </p> </section> <section id="CD013137-sec-0041"> <h4 class="title">Data extraction and management</h4> <section id="CD013137-sec-0042"> <h5 class="title">Intervention studies</h5> <p>Two review authors (TL and GT) independently extracted data from the included intervention study to a pre‐designed data extraction form that included the following. </p> <p> <ul id="CD013137-list-0009"> <li> <p>Author contact details</p> </li> <li> <p>Country</p> </li> <li> <p>Setting</p> </li> <li> <p>Dates of participant accrual</p> </li> <li> <p>Funding source</p> </li> <li> <p>Inclusion and exclusion criteria</p> </li> <li> <p>Study design</p> </li> <li> <p>Study population and baseline characteristics</p> <ul id="CD013137-list-0010"> <li> <p>number of participants enrolled;</p> </li> <li> <p>number of participants analysed;</p> </li> <li> <p>age of participants;</p> </li> <li> <p>gender of participants;</p> </li> <li> <p>type of glioma (low grade or high grade; tumour size, molecular markers);</p> </li> <li> <p>type of glioma treatment (surgery; radiotherapy; chemotherapy).</p> </li> </ul> </li> <li> <p>Intervention details</p> <ul id="CD013137-list-0011"> <li> <p>type of intervention (pre‐specified, interval or surveillance imaging), including whether it occurred pre‐treatment or post‐treatment, the interval period, and the type of scan (e.g. MRI); </p> </li> <li> <p>type of comparator (symptomatic imaging or other imaging schedule), including indications for imaging, information on the timing of the imaging (e.g. median time to first scan post‐treatment), and the type of scan. </p> </li> </ul> </li> <li> <p>'Risk of bias' assessment (see below)</p> </li> <li> <p>Duration of follow‐up</p> </li> <li> <p>Primary outcome(s) of the study</p> </li> <li> <p>Review outcomes</p> <ul id="CD013137-list-0012"> <li> <p>For time‐to‐event outcomes (overall and progression‐free survival), we planned to extract the hazard ratio (HR) with its 95% confidence interval (CI) for time points as reported by the study authors. We would have noted the definition of progression and the procedure used to identify it. Where reported, we also planned to extract dichotomous data for these outcomes at author‐specified time points. </p> </li> <li> <p>For dichotomous outcomes (e.g. death, anxiety, depression), we extracted the number of participants in each treatment arm that experienced the outcome of interest and the number of participants assessed. </p> </li> <li> <p>For continuous outcomes (e.g. quality‐of‐life scores, anxiety, depression), we planned to extract the value and standard deviation of the outcome of interest and the number of participants assessed at the relevant time point in each group. We also planned to extract change‐from‐baseline score data where reported and to note the type of scale used. </p> </li> <li> <p>We planned to extract adjusted statistics where reported.</p> </li> <li> <p>Where possible, all data extracted were those relevant to an intention‐to‐treat analysis, in which participants were analysed in the groups to which they were assigned. </p> </li> <li> <p>We resolved differences between review authors by discussion or by appeal to a third review author when necessary. </p> </li> </ul> </li> </ul> </p> </section> <section id="CD013137-sec-0043"> <h5 class="title">Studies of economic evaluation</h5> <p>We developed a data extraction form for economic evaluations based on the format and guidelines used to produce structured abstracts of economic evaluations for inclusion in the NHS Economic Evaluation Database (NHS EED), adapted to the specific requirements of this review. In addition to the outcomes described above, we planned to extract the following data. </p> <p> <ul id="CD013137-list-0013"> <li> <p>Type of evaluations</p> </li> <li> <p>Sources of effectiveness data</p> </li> <li> <p>Cost data</p> </li> <li> <p>Sources of cost data</p> </li> <li> <p>Sources of outcome valuations</p> </li> <li> <p>Analytical approach</p> </li> </ul> </p> </section> </section> <section id="CD013137-sec-0044"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>For studies of clinical effects, we assessed the risk of bias of the included study using Cochrane's tool and the criteria specified in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD013137-bbs2-0068" title="HigginsJP , AltmanDG , Sterne JA(editors) . Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Churchill R, Chandler J, Cumpston MS (editors), Cochrane Handbook for Systematic Reviews of Interventions version 5.2.0 (updated June 2017), Cochrane, 2017. Available from www.training.cochrane.org/handbook. ">Higgins 2017</a>). This included assessment of: </p> <p> <ul id="CD013137-list-0014"> <li> <p>random sequence generation;</p> </li> <li> <p>allocation concealment;</p> </li> <li> <p>blinding of participants and healthcare providers;</p> </li> <li> <p>blinding of outcome assessors;</p> </li> <li> <p>incomplete outcome data (more than 20% missing data considered high risk);</p> </li> <li> <p>selective reporting of outcomes;</p> </li> <li> <p>other possible sources of bias, such as lack of a power calculation, baseline differences in group characteristics. </p> </li> </ul> </p> <p>We assessed according to whether there was a risk of bias for the following criteria.</p> <p> <ul id="CD013137-list-0015"> <li> <p>How participants were selected or allocated to the intervention/comparison groups.</p> </li> <li> <p>Whether the intervention participants were representative of the population of interest.</p> </li> <li> <p>Whether the comparison participants were representative of the population of interest.</p> </li> <li> <p>Whether differences between the intervention and comparison groups were controlled for or absent. </p> </li> <li> <p>Any other risk of bias.</p> </li> </ul> </p> <p>Two review authors (TL and GT) assessed risk of bias independently and resolved any differences by discussion. We summarised judgements in a 'Risk of bias' table along with the characteristics of the included study and interpreted the review results in light of the overall 'Risk of bias' assessment. For more details about assessing risk of bias, see <a href="./appendices#CD013137-sec-0088">Appendix 2</a>. </p> <p>Economic evaluations would be assessed for bias in two stages. The first stage would involve assessing risk of bias from the sources of the effectiveness data. We would assess economic evaluations carried out alongside clinical studies using the Cochrane 'Risk of bias' tool, as described above. If the economic evaluation was model‐based, we would use the ROBIS tool to assess bias in the effectiveness studies (<a href="./references#CD013137-bbs2-0092" title="WhitingP , SavovićJ , HigginsJP , CaldwellDM , ReevesBC , SheaB , et al. ROBIS: a new tool to assess risk of bias in systematic reviews was developed. Journal of Clinical Epidemiology2016;69:225‐34. ">Whiting 2016</a>). The second stage involves assessing the risk of bias of the economic evidence (i.e. assessing the overall methodological quality). We would use the CHEERS and <a href="https://hsr.mumc.maastrichtuniversity.nl/consensus-health-economic-criteria-chec-list" target="_blank">Evers</a> checklists to do this (<a href="http://hsr.mumc.maastrichtuniversity.nl/consensus-health-economic-criteria-chec-list" target="_blank">hsr.mumc.maastrichtuniversity.nl/consensus‐health‐economic‐criteria‐chec‐list</a>), (<a href="./references#CD013137-bbs2-0069" title="HusereauD , DrummondM , PetrouS , CarswellC , MoherD , GreenbergD , et al. Consolidated health economic evaluation reporting standards (CHEERS) Explanation and elaboration: a report of the ISPOR health economic evaluations publication guidelines good reporting practices task force. Value in Health2013;16:231‐50. ">Husereau 2013</a>; <a href="./references#CD013137-bbs2-0090" title="ThielenFW , VanMastrigtGA , BurgersLT , BramerWM , MajoieHJ , EversSM , et al. How to prepare a systematic review of economic evaluations for clinical practice guidelines: database selection and search strategy development (part 2/3). Expert Review of Pharmacoeconomics &amp; Outcomes Research2016;16(6):705‐21. ">Thielen 2016</a>; <a href="./references#CD013137-bbs2-0091" title="VanMastrigtGA , HiligsmannM , ArtsJJ , BroosPH , KleijnenJ , EversSM , et al. How to prepare a systematic review of economic evaluations for informing evidence‐based healthcare decisions: a five‐step approach (part 1/3). Expert Review of Pharmacoeconomics &amp; Outcomes Research2016; Vol. 16, issue 6:689‐704. ">Van Mastrigt 2016</a>; <a href="./references#CD013137-bbs2-0094" title="WijnenBF , VanMastrigtGA , RedekopWK , MajoieHJ , DeKinderenRJ , EversSM . How to prepare a systematic review of economic evaluations for informing evidence‐based healthcare decisions: data extraction, risk of bias, and transferability (part 3/3). Expert review of pharmacoeconomics &amp; outcomes research2016;16(6):723‐32. ">Wijnen 2016</a>). </p> </section> <section id="CD013137-sec-0045"> <h4 class="title">Measures of treatment effect</h4> <p>We only found data for dichotomous outcomes, for which we calculated the effect size as a risk ratio (RR) with its 95% CI. </p> </section> <section id="CD013137-sec-0046"> <h4 class="title">Unit of analysis issues</h4> <p>Two review authors (TL and GT) would have reviewed unit of analysis issues according to the criteria presented in <a href="./references#CD013137-bbs2-0064" title="DeeksJJ , HigginsJP , Altman DG (editors) on behalf of the Cochrane Statistical Methods Group. Chapter 9: Analysing data and undertaking meta‐analyses. In: Higgins JPT, Churchill R, Chandler J, Cumpston MS (editors), Cochrane Handbook for Systematic Reviews of Interventions version 5.2.0 (updated June 2017), Cochrane, 2017. Available from www.training.cochrane.org/handbook. ">Deeks 2017</a> and would have resolved any disagreements by discussion. Unit of analysis issues might have included reports where there were multiple observations for the same outcome (e.g. repeated measurements with different scales or at different time points, recurring events). </p> </section> <section id="CD013137-sec-0047"> <h4 class="title">Dealing with missing data</h4> <p>We did not impute missing data. In the event of missing data, we planned to write to study authors to request the data and describe in the 'Characteristics of included studies' tables how any missing data were obtained. </p> </section> <section id="CD013137-sec-0048"> <h4 class="title">Assessment of heterogeneity</h4> <p>We planned to assess heterogeneity between intervention studies in each meta‐analysis by visual inspection of forest plots; by estimation of the percentage heterogeneity between studies that cannot be ascribed to sampling variation (<a href="./references#CD013137-bbs2-0067" title="HigginsJP , ThompsonSG , DeeksJJ , AltmanDG . Measuring inconsistency in meta‐analyses. BMJ2003;327(7414):557‐60. ">Higgins 2003</a>); by a formal statistical test of the significance of the heterogeneity (<a href="./references#CD013137-bbs2-0063" title="DeeksJJ , AltmanDG , BradburnMJ . Statistical methods for examining heterogeneity and combining results from several studies in meta‐analysis. Egger M, Davey Smith G, Altman DG (eds). Systematic reviews in health care: meta‐analysis in context. onlinelibrary.wiley.com/doi/abs/10.1002/9780470693926.ch152008. [DOI: 10.1002/9780470693926.ch15] ">Deeks 2008</a>); and, where possible, by subgroup analyses. If there was evidence of substantial heterogeneity, we would have investigated and reported the possible reasons for it. </p> </section> <section id="CD013137-sec-0049"> <h4 class="title">Assessment of reporting biases</h4> <p>If there were 10 or more intervention studies in meta‐analyses we planned to investigate reporting biases (such as publication bias) using funnel plots and planned to assess asymmetry visually. If asymmetry was suggested by a visual assessment, we planned to perform exploratory analyses to investigate it (<a href="./references#CD013137-bbs2-0089" title="SterneJA , EggerM , MoherD , BoutronI (editors) . Chapter 10: Addressing reporting biases. In: Higgins JP, Churchill R, Chandler J, Cumpston MS (editors), Cochrane handbook for systematic reviews of interventions version 5.2.0 (updated June 2017), Cochrane, 2017. Available from www.training.cochrane.org/handbook. ">Sterne 2017</a>). </p> </section> <section id="CD013137-sec-0050"> <h4 class="title">Data synthesis</h4> <section id="CD013137-sec-0051"> <h5 class="title">For interventions studies</h5> <p>We planned to conduct meta‐analyses if we judged participants, comparisons and outcomes to be sufficiently similar to ensure an answer that was clinically meaningful. We planned to use the random‐effects model with inverse variance weighting for all meta‐analyses. If any studies had multiple intervention groups, we planned to divide the ‘shared’ comparison group into the number of treatment groups and comparisons between each treatment group, and treat the split comparison group as independent comparisons. We planned to perform meta‐analysis of the results assuming that we found at least two included studies that were sufficiently similar for the findings to be clinically meaningful. When a meta‐analysis was not possible due to the availability of single studies only, we planned to enter the data from single studies into Review Manager 5 (<a href="./references#CD013137-bbs2-0082" title="Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">Review Manager 2014</a>), without totals, and grade the findings as described below. </p> </section> <section id="CD013137-sec-0052"> <h5 class="title">For studies of economic evaluation</h5> <p>We planned to summarise characteristics and results of included economic evaluations using additional tables, supplemented by a narrative summary that would compare and evaluate methods used and principal results between studies. We would also tabulate unit cost data, when available. We would report the currency and price year applicable to measures of costs in each original study, alongside measures of costs, incremental costs and incremental cost effectiveness, by study. Where details of currency and price year were available in original studies, we would convert measures of costs, incremental costs and cost effectiveness to (latest year) International Dollars value using implicit price deflators for gross domestic product (GDP) and GDP purchasing power parities (<a href="http://eppi.ioe.ac.uk/costconversion/default.aspx" target="_blank">eppi.ioe.ac.uk/costconversion/default.aspx</a>; <a href="./references#CD013137-bbs2-0088" title="ShemiltI , MugfordM , ValeL , CraigD , on behalf of the Campbell and Cochrane Economics Methods Group. Searching NHS EED and HEED to inform development of economic commentary for Cochrane Intervention Reviews. methods.cochrane.org/economics/workshops (accessed 29 November 2017). ">Shemlit 2011</a>). We would summarise details of the methodological characteristics of individual included health economics studies in the ‘Characteristics of included studies’ tables. We would conduct all elements of the economics component of this review according to current guidance on the use of economics methods in the preparation and maintenance of Cochrane Reviews (<a href="./references#CD013137-bbs2-0088" title="ShemiltI , MugfordM , ValeL , CraigD , on behalf of the Campbell and Cochrane Economics Methods Group. Searching NHS EED and HEED to inform development of economic commentary for Cochrane Intervention Reviews. methods.cochrane.org/economics/workshops (accessed 29 November 2017). ">Shemlit 2011</a>). </p> </section> <section id="CD013137-sec-0053"> <h5 class="title">GRADE, 'Summary of findings' tables and results reporting</h5> <p>For evidence from intervention studies, based on the methods described in Chapter 11 of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD013137-bbs2-0084" title="SchünemannHJ , OxmanAD , HigginsJP , VistGE , GlasziouP , AklE , et al. on behalf of the Cochrane GRADEing Methods Group and the Cochrane Statistical Methods Group. Chapter 11: Completing ‘Summary of findings’ tables and grading the confidence in or quality of the evidence. In: Higgins JPT, Churchill R, Chandler J, Cumpston MS (editors), Cochrane Handbook for Systematic Reviews of Interventions version 5.2.0 (updated June 2017). Cochrane, 2017. Available from www.training.cochrane.org/handbook. ">Schünemann 2017a</a>), we prepared a 'Summary of findings' table to present the results of the following outcomes. </p> <p> <ul id="CD013137-list-0016"> <li> <p>Overall survival</p> </li> <li> <p>Progression‐free survival</p> </li> <li> <p>Quality of life</p> </li> <li> <p>Anxiety</p> </li> </ul> </p> <p>For each assumed risk cited in the tables, we provided a rationale, and used the GRADE system to rank the quality of the evidence (<a href="./references#CD013137-bbs2-0085" title="SchünemannHJ , OxmanAD , VistGE , HigginsJP , DeeksJJ , GlasziouP , et al. on behalf of the Cochrane Applicability and Recommendations Methods Group. Chapter 12: Interpreting results and drawing conclusions. In: Higgins JPT, Churchill R, Chandler J, Cumpston MS (editors), Cochrane handbook for systematic reviews of interventions version 5.2.0 (updated June 2017). Cochrane, 2017. Available from www.training.cochrane.org/handbook. ">Schünemann 2017b</a>). Where the evidence was based on single studies, or where there was no evidence on a specific outcome, we included the outcome in the 'Summary of findings' tables and graded or explained accordingly. Two review authors would grade the evidence together. We would consider downgrading evidence of a clear effect derived from single studies with small sample sizes or few events and would resolve any differences of opinion by discussion and, if necessary, by involving a third review author. We planned to report the results of the meta‐analyses in the text based on the guidance from Cochrane Effective Practice and Organisation of Care on review results reporting and interpretation (<a href="./references#CD013137-bbs2-0065" title="EffectivePractice , Organisation of Care(EPOC) . EPOC Resources for review authors. epoc.cochrane.org/epoc‐specific‐resources‐review‐authors. Oslo: Norwegian Knowledge Centre for the Health Services;, (accessed 6 July 2016). ">EPOC 2015</a>). </p> <p>For the economic evaluation evidence, we planned to present the following findings in a table. </p> <p> <ul id="CD013137-list-0017"> <li> <p>Method of economic evaluation</p> </li> <li> <p>Costs</p> </li> <li> <p>Outcomes</p> </li> <li> <p>Incremental cost‐effectiveness ratio</p> </li> </ul> </p> </section> </section> <section id="CD013137-sec-0054"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>For intervention studies, we planned to perform subgroup analysis by the glioma grade (low grade and high grade) and molecular markers, if possible. We planned to use formal tests for subgroup differences to determine whether the effect of interventions differs according to these subgroups. Depending on these findings, we would consider whether an overall summary was meaningful. We would have also considered factors such as age, gender, type of treatment, and risk of bias in interpretation of any heterogeneity. If we had identified substantial heterogeneity, we planned to investigate it in sensitivity analyses. </p> </section> <section id="CD013137-sec-0055"> <h4 class="title">Sensitivity analysis</h4> <p>For intervention studies, we planned to perform sensitivity analysis to investigate substantial heterogeneity identified in meta‐analyses of primary outcomes and also to evaluate the effect after excluding studies at high risk of bias, to investigate how study quality affects the certainty of the findings. </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD013137-sec-0056" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD013137-sec-0056"></div> <section id="CD013137-sec-0057"> <h3 class="title">Description of studies</h3> <section id="CD013137-sec-0058"> <h4 class="title">Results of the search</h4> <section id="CD013137-sec-0059"> <h5 class="title">Intervention study searches</h5> <p>Electronic searches for intervention studies yielded 1891 deduplicated records. Of these, we selected 57 studies on title and abstract as potentially eligible studies. At this level of screening we included paediatric studies and certain other studies that would clearly be excluded based on study design because we expected included studies to be few and wanted to identify as many studies relevant to the research question as possible. We subsequently found no studies (including an additional abstract identified from the 2016 BNOS conference proceedings) that met our study selection criteria and 58 studies were excluded. We identified no eligible studies on <a href="http://www.clinicaltrials.gov" target="_blank">www.ClinicalTrials.gov</a>. </p> <p>A subsequent top‐up search conducted on 18 June 2019 yielded 173 records and led to the retrieval of two full texts: we included <a href="./references#CD013137-bbs2-0001" title="MrowczynskiOD , ZammarS , BourcierAJ , LanganST , LiaoJ , SpechtCS , et al. Utility of early post‐operative magnetic resonance imaging after glioblastoma resection: implications on patient survival. World Neurosurgery2018;120:e1171‐4. ">Mrowczynski 2018</a> and excluded <a href="./references#CD013137-bbs2-0061" title="ZaazoueMA , ManleyPE , MehdarMA , UllrichNJ , DasenbrockHH , ChordasCA , et al. Optimizing postoperative surveillance of pediatric low‐grade glioma using tumor behavior patterns. Neurosurgery 2019 Mar 20 [Epub ahead of print]. [DOI: doi.org/10.1093/neuros/nyz072] ">Zaazoue 2019</a>. See <a href="#CD013137-fig-0001">Figure 1</a>. </p> <div class="figure" id="CD013137-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram." data-id="CD013137-fig-0001" src="/cdsr/doi/10.1002/14651858.CD013137.pub2/media/CDSR/CD013137/image_n/nCD013137-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> </div> </section> <section id="CD013137-sec-0060"> <h5 class="title">Economic evaluation study searches</h5> <p>The electronic searches for studies of economic evaluation yielded a list of 58 deduplicated records; of these, we identified one study for potential eligibility. After examining the full text of <a href="./references#CD013137-bbs2-0025" title="HeinzelA , StockS , LangenKJ , MüllerD . Cost‐effectiveness analysis of FET PET guided target selection for the diagnosis of gliomas. European Journal of Nuclear Medicine and Molecular Imaging2012;39(7):1089‐96. ">Heinzel 2012</a> we agreed that the evaluation was not assessing imaging approaches for monitoring or follow‐up but approaches for diagnosis: we therefore excluded this study (i.e. we had not identified any economic evaluations). A top‐up search was carried out in June 2019, which identified a further four records: one of these was potentially eligible (<a href="./references#CD013137-bbs2-0061" title="ZaazoueMA , ManleyPE , MehdarMA , UllrichNJ , DasenbrockHH , ChordasCA , et al. Optimizing postoperative surveillance of pediatric low‐grade glioma using tumor behavior patterns. Neurosurgery 2019 Mar 20 [Epub ahead of print]. [DOI: doi.org/10.1093/neuros/nyz072] ">Zaazoue 2019</a>). We considered this study for inclusion as, although it was a paediatric study, some of the participants were over the age of 18. There was, however, no specific subgroup analysis for participants over 18 and ultimately we excluded the study. We therefore have no economic evaluations to include. </p> </section> </section> <section id="CD013137-sec-0061"> <h4 class="title">Included studies</h4> <section id="CD013137-sec-0062"> <h5 class="title">Intervention evaluation studies</h5> <p>Only one study was included (<a href="./references#CD013137-bbs2-0001" title="MrowczynskiOD , ZammarS , BourcierAJ , LanganST , LiaoJ , SpechtCS , et al. Utility of early post‐operative magnetic resonance imaging after glioblastoma resection: implications on patient survival. World Neurosurgery2018;120:e1171‐4. ">Mrowczynski 2018</a>). This was a retrospective series of 125 patients with GBM who were treated at the Pennsylvania State University Department of Neurosurgery between 2006 and 2016. The study compared early post‐operative MRI (within 48 hours of surgery) with no early post‐operative MRI. Patients were excluded if they had had a previous low‐grade glioma, and if date of death could not be accurately determined. The primary outcome in this study was overall survival, which was reported in terms of the probability of surviving one and two years, and median survival in days. Mean age was approximately 60 years overall, with slightly more men than women in the cohort. Most patients were treated with maximal safe resection and received radiotherapy (60 Gy) combined with temozolomide chemotherapy, with approximately 80% in both imaging groups completing these treatments. Just over half the patients (56%) also received adjuvant temozolomide or another treatment (e.g. bevacizumab, Optune), or both. The group characteristics were largely comparable between the intervention arms, with a slightly lower mean age and higher treatment completion rates in the early post‐operative imaging group than the no post‐operative imaging group. Authors did not report the timing of the first post‐operative (pre‐radiotherapy) MRI in the 'no early post‐operative imaging' group. </p> </section> <section id="CD013137-sec-0063"> <h5 class="title">Economic evaluation studies</h5> <p>We identified no economic evaluations for this review.</p> </section> </section> <section id="CD013137-sec-0064"> <h4 class="title">Excluded studies</h4> <section id="CD013137-sec-0065"> <h5 class="title">Intervention studies</h5> <p>We excluded the 59 studies (58 from the April 2018 search and one from the June 2019 top‐up search) for the following reasons. </p> <p> <ul id="CD013137-list-0018"> <li> <p>Different study question (<a href="./references#CD013137-bbs2-0003" title="AlbertFK , ForstingM , SartorK , AdamsHP , KunzeS . Early postoperative magnetic resonance imaging after resection of malignant glioma: objective evaluation of residual tumor and its influence on regrowth and prognosis. Neurosurgery1994;34(1):45‐60. ">Albert 1994</a>; <a href="./references#CD013137-bbs2-0006" title="ChangJH , KimCY , ChoiBS , KimYJ , KimJS , KimIA . Pseudoprogression and pseudoresponse in the management of high‐grade glioma: optimal decision timing according to the response assessment of the Neuro‐Oncology Working Group. Journal of Korean Neurosurgical Society2014;55(1):5‐11. ">Chang 2014</a>; <a href="./references#CD013137-bbs2-0007" title="ChatawayJ , StenningS , BleehenN , GrantR . Use of different outcome measures in randomised studies of malignant glioma can significantly alter the interpretation of time to progression: reanalysis of the MRC BR2 study. Journal of Neuro‐oncology1999;43(1):87‐92. ">Chataway 1999</a>; <a href="./references#CD013137-bbs2-0011" title="DanchaivijitrN , WaldmanAD , TozerDJ , BentonCE , Brasil CaseirasG , ToftsPS , et al. Low‐Grade Gliomas: Do changes in rCBV measurements at longitudinal perfusion‐weighted MR imaging predict malignant transformation?. Radiology2008;247(1):170‐8. ">Danchaivijitr 2008</a>; <a href="./references#CD013137-bbs2-0014" title="FaraceP , AmelioD , RicciardiGK , ZoccatelliG , MagonS , PizziniF , et al. Early MRI changes in glioblastoma in the period between surgery and adjuvant therapy. Journal of Neuro‐oncology2013;111(2):177‐85. ">Farace 2013</a>; <a href="./references#CD013137-bbs2-0015" title="FieldKM , PhalPM , FittG , GohC , NowakAK , RosenthalMA , et al. The role of early magnetic resonance imaging in predicting survival on Bevacizumab for recurrent glioblastoma: results from a prospective clinical trial (CABARET). Cancer2017;123(18):3576‐82. ">Field 2017</a>; <a href="./references#CD013137-bbs2-0017" title="FujimuraM , KumabeT , TominagaT , JokuraH , ShiraneR , YoshimotoT . Routine clinical adoption of magnetic resonance imaging was associated with better outcome after surgery in elderly patients with a malignant astrocytic tumour: a retrospective review. Acta Neurochirurgica2004;146(3):251‐5. ">Fujimura 2004</a>; <a href="./references#CD013137-bbs2-0018" title="GalbanCJ , ChenevertTL , MeyerCR , TsienC , LawrenceTS , HamstraDA , et al. Prospective analysis of parametric response map‐derived MRI biomarkers: identification of early and aistinct glioma response patterns not predicted by standard radiographic assessment. Clinical Cancer Research2011;17(14):4751‐60. ">Galban 2011</a>; <a href="./references#CD013137-bbs2-0021" title="GittlemanHR , LimD , KattanM , ChakravartiA , GilbertMR , LassmanAB , et al. An independently validated nomogram for individualized estimation of survival among patients with newly diagnosed glioblastoma: NRG oncology/RTOG 0525 and 0825. International Journal of Radiation Oncology2016; Vol. 96, issue 2 Supplement 1:S92. ">Gittleman 2016</a>; <a href="./references#CD013137-bbs2-0022" title="GorliaT , DelattreJY , BrandesAA , KrosJM , TaphoornMJ , KouwenhovenMC , et al. New clinical, pathological and molecular prognostic models and calculators in patients with locally diagnosed anaplastic oligodendroglioma or oligoastrocytoma. European Journal of Cancer2013;49(16):3477‐85. ">Gorlia 2013</a>; <a href="./references#CD013137-bbs2-0027" title="KlingelhoferL , MuchaD , GeigerK , KochR , vonKummerR . Prognostic value of conventional magnetic resonance imaging for adult patients with brain tumors. Clinical Neuroradiology2015;25(3):281‐9. ">Klingelhofer 2015</a>; <a href="./references#CD013137-bbs2-0030" title="LiY , LupoJM , PolleyMY , CraneJC , BianW , ChaS , et al. Serial analysis of imaging parameters in patients with newly diagnosed glioblastoma multiforme. Neuro‐oncology2011;13(5):546‐57. ">Li 2011</a>; <a href="./references#CD013137-bbs2-0034" title="MerkelA , SoeldnerD , WendlC , UrkanD , KuramatsuJB , SeligerC , et al. Early postoperative tumor progression predicts clinical outcome in glioblastoma ‐ implication for clinical trials. Journal of Neuro‐oncology2017;132(2):249‐54. ">Merkel 2017</a>; <a href="./references#CD013137-bbs2-0036" title="MilanoMT , OkunieffP , DonatelloRS , MohileNA , SulJ , WalterKA , et al. Patterns and timing of recurrence after Temozolomide‐based chemoradiation for glioblastoma. International Journal of Radiation Oncology, Biology, Physics2010;78(4):1147‐55. ">Milano 2010</a>; <a href="./references#CD013137-bbs2-0040" title="PatilVM , PandeN , ChandrasekharanA , TonseR , ChandrakanthMV , KrishnatryR , et al. SHADOW Study: Comparison of conventional clinical follow‐up with clinician led video follow‐up in newly diagnosed patients with intermediate and high grade glioma receiving adjuvant Temozolomide therapy. Journal of Clinical Oncology2017;35(15 suppl):2024. ">Patil 2017</a>; <a href="./references#CD013137-bbs2-0055" title="SreenivasanS , MadhugiriV , SasidharanG , KumarRVR . Measuring glioma volumes: A comparison of linear measurement based formulae with the manual image segmentation technique. Journal of Cancer Research and Therapeutics2016;12(1):161‐8. ">Sreenivasan 2016</a>; <a href="./references#CD013137-bbs2-0060" title="WickW , GorliaT , BadyP , PlattenM , Van DenBentMJ , TaphoornMJB , et al. Phase II study of radiotherapy and temsirolimus versus radiochemotherapy with temozolomide in patients with newly diagnosed glioblastoma without MGMT promoter hypermethylation (EORTC 26082). Clinical Cancer Research2016;22(19):4797‐806. ">Wick 2016</a>). </p> </li> <li> <p>Wrong type of study</p> <ul id="CD013137-list-0019"> <li> <p>Case report (<a href="./references#CD013137-bbs2-0010" title="CochereauJ , HerbetG , RigauV , DuffauH . Acute progression of untreated incidental WHO Grade II glioma to glioblastoma in an asymptomatic patient. Journal of Neurosurgery2016;124(1):141‐5. ">Cochereau 2016</a>; <a href="./references#CD013137-bbs2-0019" title="GalldiksN , KrachtLW , BurghausL , UllrichRT , BackesH , BrunnA , et al. Patient‐tailored, imaging‐guided, long‐term temozolomide chemotherapy in patients with glioblastoma. Molecular Imaging2010;9(1):40‐6. ">Galldiks 2010</a>; <a href="./references#CD013137-bbs2-0053" title="SinghAD , EasawJC . Does neurologic deterioration help to differentiate between pseudoprogression and true disease progression in newly diagnosed glioblastoma multiforme?. Current Oncology2012;19(4):e295‐8. ">Singh 2012</a>) </p> </li> <li> <p>Non‐comparative case series (<a href="./references#CD013137-bbs2-0023" title="GuiC , KosteniukSE , LauJC , MegyesiJF . Tumor growth dynamics in serially‐imaged low‐grade glioma patients. Journal of Neuro‐oncology2018;139:167‐75. ">Gui 2018</a>; <a href="./references#CD013137-bbs2-0029" title="LeonardJR , WitherspoonLR , MahaleyMSJr , GoodrichJK . Value of sequential postoperative brain scans in patients with anaplastic gliomas. Journal of Neurosurgery1975;42(5):551‐6. ">Leonard 1975</a>; <a href="./references#CD013137-bbs2-0031" title="LorimerCF , HannaC , SaranF , ChalmersA , BrockJ . Challenges to treating older glioblastoma patients: the influence of clinical and tumour characteristics on survival outcomes. Clinical Oncology2017;29(11):739‐47. ">Lorimer 2017</a>; <a href="./references#CD013137-bbs2-0043" title="QuinnJL , 3rd . Serial brain scans in glioblastoma multiforme. Radiology1971;101(2):367‐70. ">Quinn 1971</a>; <a href="./references#CD013137-bbs2-0054" title="SpitaelsJ , DevriendtD , SadeghiN , LuceS , DeWitteO , GoldmanS , et al. Management of supratentorial recurrent low‐grade glioma: A multidisciplinary experience in 35 adult patients. Oncology Letters2017;14(3):2789‐95. ">Spitaels 2017</a>) </p> </li> <li> <p>Other non‐comparative study (<a href="./references#CD013137-bbs2-0024" title="HamdanA , KaneP . Is routine interval surveillance imaging after completion of primary treatment effective at detecting recurrence in GBM patients?. Neuro‐oncology. BNOS Conference proceedings 2016. Jan 2017; Vol. Abstract pp73:i20. ">Hamdan 2017</a>; <a href="./references#CD013137-bbs2-0033" title="MahaleyMSJr , MitchellWG , WhaleyR , DudkaLF , SymonsMJ . The relative roles of neurological examination, functional abilities, and computed tomography in the definition of treatment failure in patients with anaplastic gliomas. Surgical Neurology1983;20(4):297‐300. ">Mahaley 1983</a>; <a href="./references#CD013137-bbs2-0035" title="MeyersCA , HessKR . Multifaceted end points in brain tumor clinical trials: cognitive deterioration precedes MRI progression. Neuro‐oncology2003;5(2):89‐95. ">Meyers 2003</a>; <a href="./references#CD013137-bbs2-0048" title="ScocciantiS , MagriniSM , RicardiU , DettiB , BuglioneM , SottiG , et al. Patterns of care and survival in a retrospective analysis of 1059 patients with glioblastoma multiforme treated between 2002 and 2007: A multicenter study by the central nervous system study group of Airo (Italian Association of Radiation Oncology). Neurosurgery2010;67(2):446‐58. ">Scoccianti 2010</a>; <a href="./references#CD013137-bbs2-0049" title="SeizM , FreyschlagCF , SchenkelS , WeissC , ThomeC , SchmiederK , et al. Management of patients with low‐grade gliomas ‐ A survey among german neurosurgical departments. Central European Neurosurgery2011;72(4):186‐91. ">Seiz 2011</a>; <a href="./references#CD013137-bbs2-0058" title="WangCH , RockhillJK , MrugalaM , PeacockDL , LaiA , JuseniusK , et al. Prognostic significance of growth kinetics in newly diagnosed glioblastomas revealed by combining serial imaging with a novel biomathematical model. American Association for Cancer Research2009;69(23):9133‐40. ">Wang 2009</a>; <a href="./references#CD013137-bbs2-0059" title="WeizmanL , SiraLB , JoskowiczL , RubinDL , YeomKW , ConstantiniS , et al. Semiautomatic segmentation and follow‐up of multicomponent low‐grade tumors in longitudinal brain MRI studies. Medical Physics2014;41(5):052303‐14. ">Weizman 2014</a>) </p> </li> <li> <p>Review (<a href="./references#CD013137-bbs2-0002" title="AbrigoJM , FountainDM , ProvenzaleJM , LawEK , KwongJS , HartMG , et al. Magnetic resonance perfusion for differentiating low‐grade from high‐grade gliomas at first presentation. Cochrane Database of Systematic Reviews2018, Issue 1. [DOI: 10.1002/14651858.CD011551.pub2] ">Abrigo 2018</a>; <a href="./references#CD013137-bbs2-0008" title="ChristieJH , GoRT , SchapiroRL . The diagnostic value of serial brain scanning. CRC Critical Reviews in Clinical Radiology and Nuclear Medicine1975;7(2):161‐85. ">Christie 1975</a>; <a href="./references#CD013137-bbs2-0009" title="CihoricN , TsikkinisA , MinnitiG , LagerwaardFJ , HerrlingerU , MathierE , et al. Current status and perspectives of interventional clinical trials for glioblastoma – analysis of ClinicalTrials.gov. 2017 Radiation Oncology;12(1):1. ">Cihoric 2017</a>; <a href="./references#CD013137-bbs2-0016" title="FoukeSJ , BenzingerT , GibsonD , RykenTC , KalkanisSN , OlsonJJ . The role of imaging in the management of adults with diffuse low grade glioma: a systematic review and evidence‐based clinical practice guideline. Journal of Neuro‐oncology2015;125(3):457‐79. ">Fouke 2015</a>; <a href="./references#CD013137-bbs2-0039" title="Oberheim BushNA , ChangS . Treatment strategies for low‐grade glioma in adults. Journal of Oncology Practice2016;12(12):1235‐41. ">Oberheim Bush 2016</a>; <a href="./references#CD013137-bbs2-0046" title="SangheraP , RamplingR , HaylockB , JefferiesS , McBainC , ReesJH , et al. The concepts, diagnosis and management of early imaging changes after therapy for glioblastomas. Clinical Oncology2012;24(3):216–27. ">Sanghera 2012</a>; <a href="./references#CD013137-bbs2-0051" title="ShahAH , MadhavanK , HerosD , RaperDM , IorgulescuJB , LallyBE , et al. The management of incidental low‐grade gliomas using magnetic resonance imaging: systematic review and optimal treatment paradigm. Neurosurgical Focus2011;31(6):E12. ">Shah 2011</a>; <a href="./references#CD013137-bbs2-0052" title="ShiroishiMS , BookerMT , AgarwalM , JainN , NaghiI , LernerA , et al. Post treatment evaluation of central nervous system gliomas. Magnetic Resonance Imaging Clinics of North America2013;21(2):241‐68. ">Shiroishi 2013</a>). </p> </li> <li> <p>Commentary/opinion paper (<a href="./references#CD013137-bbs2-0013" title="EasawJC , MasonWP , PerryJ , LaperriereN , EisenstatDD , DelMaestroR , et al. Canadian recommendations for the treatment of recurrent or progressive glioblastoma multiforme. Current Oncology2011;18(3):e126‐36. ">Easaw 2011</a>; <a href="./references#CD013137-bbs2-0032" title="MacdonaldDR , CascinoTL , ScholdSCJr , CairncrossJG . Response criteria for phase II studies of supratentorial malignant glioma. Journal of Clinical Oncology1990;8(7):1277‐80. ">Macdonald 1990</a>; <a href="./references#CD013137-bbs2-0038" title="NeaguMR , HuangRY , ReardonDA , WenPY . How treatment monitoring is influencing treatment decisions in glioblastomas. Current Treatment Options in Neurology2015;17:1‐15. ">Neagu 2015</a>; <a href="./references#CD013137-bbs2-0044" title="ReardonDA , BallmanKV , BucknerJC , ChangSM , EllingsonBM . Impact of imaging measurements on response assessment in glioblastoma clinical trials. Neuro‐oncology2014;16 Suppl 7:vii24‐35. ">Reardon 2014</a>; <a href="./references#CD013137-bbs2-0045" title="SabattiniL , PiazzaGC , FinizioFS . Programmed serial CT scans in the surgical and radio‐chemotherapeutic management of cerebral gliomas. Journal of Neurosurgical Sciences1980;24(1):33‐6. ">Sabattini 1980</a>). </p> </li> <li> <p>Qualitative study (<a href="./references#CD013137-bbs2-0020" title="GeerCP , SimondsJ , AnveryA , ChenMY , BurdetteJH , ZapadkaME , et al. Does MR perfusion imaging impact management decisions for patients with brain tumors? A prospective study. American Journal of Neuroradiology2012;33(3):556‐62. ">Geer 2012</a>) </p> </li> </ul> </li> <li> <p>Wrong study population (<a href="./references#CD013137-bbs2-0004" title="AliZS , LangSS , SuttonLN . Conservative management of presumed low‐grade gliomas in the asymptomatic pediatric population. World Neurosurgery2014;81(2):368‐73. ">Ali 2014</a>; <a href="./references#CD013137-bbs2-0012" title="deGraafN , HewJM , FockJM , KampsWA , deGraafSS . Predictive value of clinical evaluation in the follow‐up of children with a brain tumor. Medical and Pediatric Oncology2002;38(4):254‐7. ">de Graaf 2002</a>; <a href="./references#CD013137-bbs2-0026" title="KimAH , ThompsonEA , GovernaleLS , SantaC , CahillK , KieranMW , et al. Recurrence after gross total resection of low‐grade pediatric brain tumors: The frequency and timing of postoperative imaging. Journal of Neurosurgery. Pediatrics2014;14(4):356‐64. ">Kim 2014</a>; <a href="./references#CD013137-bbs2-0028" title="KoronesDN , ButterfieldR , MeyersSP , ConstineLS . The role of surveillance magnetic resonance imaging (MRI) scanning in detecting recurrent brain tumors in asymptomatic children. Journal of Neuro‐oncology2001;53(1):33‐8. ">Korones 2001</a>; <a href="./references#CD013137-bbs2-0041" title="PerreaultS , LoberRM , CarretAS , ZhangG , HershonL , DecarieJC , et al. Surveillance imaging in children with malignant CNS tumors: low yield of spine MRI. Journal of Neuro‐oncology2014;116:617‐23. ">Perreault 2014</a>; <a href="./references#CD013137-bbs2-0042" title="PoussaintTY , KocakM , VajapeyamS , PackerRI , RobertsonRL , GeyerR , et al. MRI as a central component of clinical trials analysis in brainstem glioma: a report from the Pediatric Brain Tumor Consortium (PBTC). Neuro‐oncology2011;13(4):417‐27. ">Poussaint 2011</a>; <a href="./references#CD013137-bbs2-0047" title="SaundersDE , PhippsKP , WadeAM , HaywardRD . Surveillance imaging strategies following surgery and/or radiotherapy for childhood cerebellar low‐grade astrocytoma. Journal of Neurosurgery2005;102 Pediatrics(SUPPL 2):172‐8. ">Saunders 2005</a>; <a href="./references#CD013137-bbs2-0050" title="SethiR , AllenJ , DonahueB , KarajannisM , GardnerS , WisoffJ , et al. Prospective neuraxis MRI surveillance reveals a high risk of leptomeningeal dissemination in diffuse intrinsic pontine glioma. Journal of Neuro‐oncology2011;102(1):121‐7. ">Sethi 2011</a>; <a href="./references#CD013137-bbs2-0056" title="SuttonLN , CnaanA , KlattL , ZhaoH , ZimmermanR , NeedleM , et al. Postoperative surveillance imaging in children with cerebellar astrocytomas. Journal of Neurosurgery1996;84(5):721‐25. ">Sutton 1996</a>; <a href="./references#CD013137-bbs2-0057" title="UdakaYT , Yeh‐NayreLA , AmeneCS , VandenBergSR , LevyML , CrawfordJR . Recurrent pediatric central nervous system low‐grade gliomas: The role of surveillance neuroimaging in asymptomatic children. Journal of Neurosurgery. Pediatrics2012;11(2):119‐26. ">Udaka 2012</a>; <a href="./references#CD013137-bbs2-0061" title="ZaazoueMA , ManleyPE , MehdarMA , UllrichNJ , DasenbrockHH , ChordasCA , et al. Optimizing postoperative surveillance of pediatric low‐grade glioma using tumor behavior patterns. Neurosurgery 2019 Mar 20 [Epub ahead of print]. [DOI: doi.org/10.1093/neuros/nyz072] ">Zaazoue 2019</a>). </p> </li> </ul> <ul id="CD013137-list-0020"> <li> <p>Several studies had more than one reason for exclusion. For two older studies (<a href="./references#CD013137-bbs2-0005" title="AoyamaI . Usefulness of serial CT scans for evaluation of histology and prognosis in gliomas. Nippon geka hokan ‐ Archiv für japanische Chirurgie1982;51(4):566‐82. ">Aoyama 1982</a>; <a href="./references#CD013137-bbs2-0037" title="MuellerH , KaernbachA . Serial CT scans in the treatment of brain gliomas with CCNU and radiation ‐ with or without operation. Neurochirurgia1981;24(Suppl):416. ">Mueller 1981</a>), we were unable to obtain the full text. </p> </li> </ul> </p> <p>In addition, we excluded <a href="./references#CD013137-bbs2-0025" title="HeinzelA , StockS , LangenKJ , MüllerD . Cost‐effectiveness analysis of FET PET guided target selection for the diagnosis of gliomas. European Journal of Nuclear Medicine and Molecular Imaging2012;39(7):1089‐96. ">Heinzel 2012</a> from the economic search as it related to a different study question, making the total number of excluded studies 59. </p> </section> </section> </section> <section id="CD013137-sec-0066"> <h3 class="title">Risk of bias in included studies</h3> <p>The only included intervention evaluation study was a non‐randomised retrospective study that we assessed as being at high risk of bias overall, mainly due to high risk of selection bias because the decision about whether or not a patient received the intervention was left to the preference and discretion of the attending clinician (<a href="./references#CD013137-bbs2-0001" title="MrowczynskiOD , ZammarS , BourcierAJ , LanganST , LiaoJ , SpechtCS , et al. Utility of early post‐operative magnetic resonance imaging after glioblastoma resection: implications on patient survival. World Neurosurgery2018;120:e1171‐4. ">Mrowczynski 2018</a>). Thus, intervention groups might have been divided across different practitioners and have been managed differently. The study population was, however, appropriate in terms of disease evaluated (GBM) and treatment received; and available patient baseline characteristics were comparable between the groups and any differences that might have favoured better outcomes in the intervention group (e.g. lower mean age) did not do so. Molecular information, early re‐operation for residual enhancing disease, and second line and subsequent therapies were not reported. In addition, the reviewer team had concerns about attrition bias from patients who did not have their date of death recorded in the site's system, because the number of patients eligible and included in the study from a 10‐year period at the neuro‐oncology centre seemed low. </p> </section> <section id="CD013137-sec-0067"> <h3 class="title" id="CD013137-sec-0067">Effects of interventions</h3> <p>See: <a href="./full#CD013137-tbl-0001"><b>Summary of findings for the main comparison</b> </a> </p> <section id="CD013137-sec-0068"> <h4 class="title">Evidence from intervention evaluation studies</h4> <section id="CD013137-sec-0069"> <h5 class="title">Comparison: Early post‐operative imaging versus no early post‐operative imaging</h5> <p>The evidence is derived from one included study only (<a href="./references#CD013137-bbs2-0001" title="MrowczynskiOD , ZammarS , BourcierAJ , LanganST , LiaoJ , SpechtCS , et al. Utility of early post‐operative magnetic resonance imaging after glioblastoma resection: implications on patient survival. World Neurosurgery2018;120:e1171‐4. ">Mrowczynski 2018</a>). </p> <section id="CD013137-sec-0070"> <h6 class="title">Overall survival</h6> <p>Findings from the single study with 125 subjects suggested little or no difference between early and no early post‐operative imaging with respect to the proportion of deaths at one year after diagnosis (RR 0.86, 95% CI 0.61 to 1.21; 48% vs 55% had died, respectively; very low certainty evidence; <a href="./references#CD013137-fig-0002" title="">Analysis 1.1</a>) or two years after diagnosis (RR 1.06, 95% CI 0.91 to 1.25; 86% vs 81% had died, respectively; very low certainty evidence; <a href="./references#CD013137-fig-0003" title="">Analysis 1.2</a>). </p> <p>We found no data related to other review outcomes or comparisons.</p> </section> </section> </section> <section id="CD013137-sec-0071"> <h4 class="title">Evidence from economic evaluation studies</h4> <p>There was no evidence regarding the cost‐effectiveness of different imaging strategies for monitoring glioma in adults. </p> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD013137-sec-0072" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD013137-sec-0072"></div> <section id="CD013137-sec-0073"> <h3 class="title" id="CD013137-sec-0073">Summary of main results</h3> <p>This systematic review found one retrospective, comparative study (125 patients) of early post‐operative imaging compared with no early post‐operative magnetic resonance imaging for the management of GBM. Evidence suggested that there may be little or no difference with early imaging after surgery compared with no early imaging in patient survival at one and two years after diagnosis when the standard of care for GBM patients was combined radiotherapy and temozolomide after maximal surgical resection. However, we assessed the study as having a high risk of bias for various reasons mainly related to its design, and hence we assessed the evidence as very low quality/certainty. </p> <p>We found no evidence on the comparative benefits and risks of other types of imaging strategies that could inform guidance on the optimal timing of surveillance imaging. </p> </section> <section id="CD013137-sec-0074"> <h3 class="title" id="CD013137-sec-0074">Overall completeness and applicability of evidence</h3> <p>There is little evidence to inform clinical practice guidelines with respect to the effectiveness of different imaging strategies to improve health outcomes among people with gliomas. </p> <p>This review has identified no evidence to inform decision makers on the efficiency of different imaging strategies in the management of adults with glioma. </p> </section> <section id="CD013137-sec-0075"> <h3 class="title" id="CD013137-sec-0075">Quality of the evidence</h3> <p>The evidence on the relative effectiveness of early post‐operative imaging is of very low quality/certainty and further research is needed. Evidence on other imaging strategies is absent. </p> <p>This review has identified no evidence on the cost effectiveness of different imaging strategies in the management of adults with glioma. </p> </section> <section id="CD013137-sec-0076"> <h3 class="title" id="CD013137-sec-0076">Potential biases in the review process</h3> <p>We followed Cochrane methodology for reviews of interventions and are unaware of any potential biases in the review process. We found only one comparative study of the different imaging approaches for GBM in the early post‐operative interval, and none for other types of glioma. We were unable therefore to synthesize any evidence by meta‐analysis. Although we found some studies that had interesting data on imaging time points (for example, from certain studies conducted in paediatric populations), none fulfilled the review eligibility criteria and could inform the review question directly. Whilst we considered deviating from the protocol to allow for potential inclusion of these studies, we decided rather to remain true to the protocol and discuss the strengths and limitations of findings from these 'indirect' studies in the 'Discussion' section of the review. This seemed appropriate as Cochrane Reviews intrinsically evaluate quality/certainty of evidence, and we considered that any evidence potentially derived from such indirect studies would most likely be very low certainty in the context of the review question. This is particularly the case for paediatric studies, since the disease processes and issues surrounding imaging, such as risk from anaesthesia and added parental anxieties, are sufficiently different from the context in adults. </p> <p>Whilst some might question the value of a relatively 'empty' review with only one included study of limited quality, we believed that identifying knowledge gaps in clinical practice is as important as finding evidence to support a clinical practice. Without identifying the knowledge gaps, meaningful discussions and research planning on how high‐quality studies can be designed to fill the gaps are precluded. </p> </section> <section id="CD013137-sec-0077"> <h3 class="title" id="CD013137-sec-0077">Agreements and disagreements with other studies or reviews</h3> <p>The primary aim of imaging in glioma management is to identify definitive disease progression, as this leads to a change in management. As with any surveillance examination, there will be many visits in which no change of treatment is instigated. To our knowledge, the first review that looked at potential benefits of serial imaging in neuro‐oncology was <a href="./references#CD013137-bbs2-0008" title="ChristieJH , GoRT , SchapiroRL . The diagnostic value of serial brain scanning. CRC Critical Reviews in Clinical Radiology and Nuclear Medicine1975;7(2):161‐85. ">Christie 1975</a>, which introduced the concept that early transient changes do not reflect true disease progression. A more recent systematic review and evidence‐based clinical practice guideline on low‐grade gliomas in adults did not attempt to answer questions around the effectiveness of imaging (<a href="./references#CD013137-bbs2-0016" title="FoukeSJ , BenzingerT , GibsonD , RykenTC , KalkanisSN , OlsonJJ . The role of imaging in the management of adults with diffuse low grade glioma: a systematic review and evidence‐based clinical practice guideline. Journal of Neuro‐oncology2015;125(3):457‐79. ">Fouke 2015</a>). One recent review highlighted that trials of imaging are under‐represented in current research prioritisation (<a href="./references#CD013137-bbs2-0009" title="CihoricN , TsikkinisA , MinnitiG , LagerwaardFJ , HerrlingerU , MathierE , et al. Current status and perspectives of interventional clinical trials for glioblastoma – analysis of ClinicalTrials.gov. 2017 Radiation Oncology;12(1):1. ">Cihoric 2017</a>), and another called for rigorous clinical evaluation of advanced imaging techniques that might distinguish pseudoprogression and pseudoresponse from true progression and response (<a href="./references#CD013137-bbs2-0052" title="ShiroishiMS , BookerMT , AgarwalM , JainN , NaghiI , LernerA , et al. Post treatment evaluation of central nervous system gliomas. Magnetic Resonance Imaging Clinics of North America2013;21(2):241‐68. ">Shiroishi 2013</a>). </p> <p>In the absence of evidence on imaging strategies for low‐grade gliomas, a few excluded studies deserve mention: <a href="./references#CD013137-bbs2-0026" title="KimAH , ThompsonEA , GovernaleLS , SantaC , CahillK , KieranMW , et al. Recurrence after gross total resection of low‐grade pediatric brain tumors: The frequency and timing of postoperative imaging. Journal of Neurosurgery. Pediatrics2014;14(4):356‐64. ">Kim 2014</a> is a paediatric study that demonstrates the type of research that could potentially be undertaken in adults to generate evidence, particularly since it considers both clinical and economic aspects of imaging options. This retrospective study of 67 children with recurrent grade 1 gliomas evaluated the timing and frequency of post‐operative imaging with respect to recurrence‐free survival and cost in the health system in the USA. Thirteen asymptomatic recurrences occurred and all were detected by imaging, with a mean time to recurrence of 32.4 months (ranging from 2.9 to 128.5 months). Comparing a standard imaging schedule (comprising an MRI every 3 months for the first year, 6 months for the second year, yearly until year 5 and then 2 to 3 yearly thereafter) with a tailored, less frequent schedule (comprising imaging at 0 months, 3 months, 1 year, 2 years, and 5 years after surgery), the authors found that the less frequent schedule (5 scans instead of 10) was sufficient. It is not known whether detection of asymptomatic recurrence improved survival outcomes in this cohort, however, given the slow‐growing nature of the tumour. The authors proposed the less intensive imaging schedule as having potential psychosocial and economic benefits. </p> <p>Similarly, another study conducted in the USA analysed detection efficiency of different post‐operative surveillance imaging protocols for paediatric low‐grade gliomas (<a href="./references#CD013137-bbs2-0061" title="ZaazoueMA , ManleyPE , MehdarMA , UllrichNJ , DasenbrockHH , ChordasCA , et al. Optimizing postoperative surveillance of pediatric low‐grade glioma using tumor behavior patterns. Neurosurgery 2019 Mar 20 [Epub ahead of print]. [DOI: doi.org/10.1093/neuros/nyz072] ">Zaazoue 2019</a>). Based on retrospective data of 517 patients who underwent 8061 scans, they reported that an 8‐image surveillance protocol (comprising imaging at 0 months, 3 months, 6 months, 1 year, 2 years, 3 years, 5 years and 6 years) detected progression at comparable rates to the 15‐image protocol currently in practice in that setting. For patients who underwent gross total resection, this could be further reduced to six scans. </p> <p>By comparison, for adults with less aggressive gliomas (excluding grade 1) the post‐operative imaging surveillance schedule currently suggested by NICE comprises eight or nine scans in the first five years after surgery. Thus retrospective reviews of adult data similar to the paediatric studies could help to clarify whether this type of schedule is effective, particularly since numbers attainable from several co‐ordinated multi‐centre and international clinical trials would be larger than those available in paediatric practice. </p> <p>With respect to high‐grade gliomas another excluded study, the findings of which were reported at the 2016 British Neuro‐Oncology Society conference and available in abstract form only, compared recurrence detection rates of interval scans with those of symptomatic scans among 38 GBM patients who had completed the full standard of care chemoradiotherapy regimen (<a href="./references#CD013137-bbs2-0024" title="HamdanA , KaneP . Is routine interval surveillance imaging after completion of primary treatment effective at detecting recurrence in GBM patients?. Neuro‐oncology. BNOS Conference proceedings 2016. Jan 2017; Vol. Abstract pp73:i20. ">Hamdan 2017</a>). Authors reported that symptomatic scans (n = 12) detected more instances of recurrence than interval scans (n = 145) in this selected group of patients (58.3% vs 22.7%, respectively). In addition, none of these optimally treated patients had disease progression after a fifth stable routine interval scan (presumably within the study period, which was 2004 to 2012). While comparing symptomatic and surveillance imaging, these scans were being carried out in the same cohort, not between two cohorts of differently‐managed patients, and there is no indication of whether this partitioning was done based on actual clinical presence or absence of symptoms and signs, or whether this was based on imaging being on or off schedule ‐ some surveillance imaging is still performed when patients are symptomatic or clinically worsening. There is also no indication of how progressive disease was diagnosed, and whether confirmation of progression on symptomatic imaging was back‐dated to the time of initial ‐ sometimes asymptomatic ‐ suspected progression, as happens in clinical trials using response assessment in neuro‐oncology (RANO) criteria for example. The number of patients (n = 38) and number of symptomatic scans (n = 12) are also low, and there is no way to determine the differential impact of symptomatic versus surveillance imaging on the summary data included in the abstract. Surveillance imaging detected a higher absolute number of progression events than symptomatic imaging (33 versus 7, which of note does not sum to the quoted number of 38 participants). There are no results presented which address whether the asymptomatic progression was associated with different overall outcomes. However, mathematical modelling using a larger database, as suggested by these authors, would appear a reasonable approach to aid in determining the optimal timing of interval scans for low‐ and high‐grade gliomas. Such modelling could use prognostic algorithms to stratify patients into surveillance imaging pathways, and tailoring these pathways to risk factors should optimise resource use (<a href="./references#CD013137-bbs2-0041" title="PerreaultS , LoberRM , CarretAS , ZhangG , HershonL , DecarieJC , et al. Surveillance imaging in children with malignant CNS tumors: low yield of spine MRI. Journal of Neuro‐oncology2014;116:617‐23. ">Perreault 2014</a>). </p> <p>Several studies have evaluated the predictive value of various clinical (patient age, gender, performance status, extent of resection, radiotherapy and chemotherapy) and tumour characteristics (location, volume, histopathology), as well as imaging and molecular biomarkers (<a href="./references#CD013137-bbs2-0022" title="GorliaT , DelattreJY , BrandesAA , KrosJM , TaphoornMJ , KouwenhovenMC , et al. New clinical, pathological and molecular prognostic models and calculators in patients with locally diagnosed anaplastic oligodendroglioma or oligoastrocytoma. European Journal of Cancer2013;49(16):3477‐85. ">Gorlia 2013</a>; <a href="./references#CD013137-bbs2-0031" title="LorimerCF , HannaC , SaranF , ChalmersA , BrockJ . Challenges to treating older glioblastoma patients: the influence of clinical and tumour characteristics on survival outcomes. Clinical Oncology2017;29(11):739‐47. ">Lorimer 2017</a>; <a href="./references#CD013137-bbs2-0080" title="PignattiF , Van denBentM , CurranD , DebruyneC , SylvesterR , TherasseP , et al. Prognostic factors for survival in adult patients with cerebral low‐grade glioma. Journal of Clinical Oncology2002;20(8):2076‐84. ">Pignatti 2002</a>; <a href="./references#CD013137-bbs2-0081" title="ReesJ , WattH , JägerHR , BentonC , TozerD , ToftsP , et al. Volumes and growth rates of untreated adult low‐grade gliomas indicate risk of early malignant transformation. European Journal of Radiology2009;72(1):54‐64. ">Rees 2009</a>). Assessing individual tumour growth rates through serial imaging in the first year after diagnosis could also be helpful by distinguishing those low‐grade gliomas that have a higher risk of progression from those that are in a slow growth phase (<a href="./references#CD013137-bbs2-0023" title="GuiC , KosteniukSE , LauJC , MegyesiJF . Tumor growth dynamics in serially‐imaged low‐grade glioma patients. Journal of Neuro‐oncology2018;139:167‐75. ">Gui 2018</a>; <a href="./references#CD013137-bbs2-0059" title="WeizmanL , SiraLB , JoskowiczL , RubinDL , YeomKW , ConstantiniS , et al. Semiautomatic segmentation and follow‐up of multicomponent low‐grade tumors in longitudinal brain MRI studies. Medical Physics2014;41(5):052303‐14. ">Weizman 2014</a>). A prognostic algorithm that incorporates some or all these factors might, therefore, reliably predict tumour behaviour and facilitate stratification of patients into different surveillance imaging pathways. It could also be important to consider patient preferences as a component of any potential algorithm. Whilst there is currently little known about the potential adverse psychological effects of surveillance imaging, <a href="./references#CD013137-bbs2-0026" title="KimAH , ThompsonEA , GovernaleLS , SantaC , CahillK , KieranMW , et al. Recurrence after gross total resection of low‐grade pediatric brain tumors: The frequency and timing of postoperative imaging. Journal of Neurosurgery. Pediatrics2014;14(4):356‐64. ">Kim 2014</a> and others have pointed out that less frequent imaging might reduce its psychological burden, and hence might be preferred by patients, although the obverse may also be the case for some patients and carers who find regular imaging reassuring. Preferences could be assessed in a future survey or study. </p> <p>In most developed country settings, people receiving treatment for glioma are encouraged to participate in clinical trials (<a href="./references#CD013137-bbs2-0075" title="National Comprehensive Cancer Network. NCCN Guidelines version 1. 2018. Central Nervous System Cancers. www.nccn.org/store/login/login.aspx?ReturnURL=https://www.nccn.org/professionals/physician_gls/pdf/cns.pdf (accessed 12 April 2018). ">NCCN 2018</a>), which often employ imaging to detect progressive disease at more frequent intervals than suggested in clinical guidance. Thus, it may be challenging to conduct a randomised trial solely to answer the question of the optimal timing of imaging in glioma, particularly if a comparison of generic schedules may be contrary to a more individualised approach. </p> <p>Finally, in addition to 'when' to image, 'how' to image needs research. We may not be realising any benefit from early/pre‐symptomatic diagnosis of progression because we lack the appropriate stratification tools and treatments. If we had improved techniques that could detect meaningful changes in tumour behaviour before any symptoms present, it might lead to improved decision‐making with regards to continuing or changing treatment and subsequently better patient outcomes. One such example is 2‐hydroxyglutarate (2HG) magnetic resonance spectroscopy, which can provide a non‐invasive biomarker of IDH mutation status and could be used to inform follow‐up approaches (<a href="./references#CD013137-bbs2-0071" title="LeatherT , JenkinsonMD , DasK , PoptaniH . Magnetic Resonance Spectroscopy for detection of 2‐hydroxyglutarate as a biomarker for IDH mutation in gliomas. Metabolites2017;7(2):E29. ">Leather 2017</a>). Biopsies of blood or cerebrospinal fluid may also be used to direct such decisions as this technology improves (<a href="./references#CD013137-bbs2-0087" title="ShankarGM , BalajL , StottSL , NahedB , CarterBS . Liquid biopsy for brain tumors. Expert Review of Molecular Diagnostics2017;17(10):943‐47. ">Shankar 2017</a>). In the future, these could complement (or even partly replace) surveillance imaging and should be borne in mind in the design of future studies. </p> <section id="CD013137-sec-0078"> <h4 class="title">Economic evidence</h4> <p>There is a paucity of evidence regarding the efficiency and cost effectiveness of different imaging strategies. We found no studies that examined the cost effectiveness of different imaging strategies for monitoring and follow‐up of adults with glioma but there was one excluded study that built a decision model assessing different imaging strategies for diagnosing glioma (<a href="./references#CD013137-bbs2-0025" title="HeinzelA , StockS , LangenKJ , MüllerD . Cost‐effectiveness analysis of FET PET guided target selection for the diagnosis of gliomas. European Journal of Nuclear Medicine and Molecular Imaging2012;39(7):1089‐96. ">Heinzel 2012</a>). This study used a decision tree model to assess whether the cost effectiveness of the combined use of 18F‐fluoroethyl‐L‐tyrosine (FET) PET and MRI may be superior to MRI alone. The study concludes that the combined strategy had an 18.5% increase in the likelihood of correct diagnosis. If the time horizon of this model could be extended for the entire course of the disease, the costs and benefits of these two imaging strategies could be explored. Another excluded study examined post‐operative interval imaging in a paediatric population (<a href="./references#CD013137-bbs2-0061" title="ZaazoueMA , ManleyPE , MehdarMA , UllrichNJ , DasenbrockHH , ChordasCA , et al. Optimizing postoperative surveillance of pediatric low‐grade glioma using tumor behavior patterns. Neurosurgery 2019 Mar 20 [Epub ahead of print]. [DOI: doi.org/10.1093/neuros/nyz072] ">Zaazoue 2019</a>). The study concluded that fewer post‐operative surveillance imaging intervals were necessary to manage low‐grade glioma in a paediatric population compared to standard practice. As discussed above the post‐operative imaging surveillance schedule for adults suggests at least eight scans. If these results were generalisable to an adult population this could result in a more efficient use of imaging resources in the health care system. Future studies modelling the disease progression with different imaging strategies and intervals would aid decision makers in understanding the optimum way to manage adults with glioma from the perspective of both the patient and the health care system. </p> </section> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD013137-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013137.pub2/media/CDSR/CD013137/urn:x-wiley:14651858:media:CD013137:CD013137-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013137.pub2/media/CDSR/CD013137/image_t/tCD013137-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram." data-id="CD013137-fig-0001" src="/cdsr/doi/10.1002/14651858.CD013137.pub2/media/CDSR/CD013137/image_n/nCD013137-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013137.pub2/full#CD013137-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013137.pub2/media/CDSR/CD013137/image_n/nCD013137-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013137-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013137.pub2/media/CDSR/CD013137/urn:x-wiley:14651858:media:CD013137:CD013137-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013137.pub2/media/CDSR/CD013137/image_t/tCD013137-CMP-001-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Early post‐surgery imaging vs no early imaging, Outcome 1 Overall survival (deaths at 1 year)." data-id="CD013137-fig-0002" src="/cdsr/doi/10.1002/14651858.CD013137.pub2/media/CDSR/CD013137/image_n/nCD013137-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Early post‐surgery imaging vs no early imaging, Outcome 1 Overall survival (deaths at 1 year). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013137.pub2/references#CD013137-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013137.pub2/media/CDSR/CD013137/image_n/nCD013137-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013137-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013137.pub2/media/CDSR/CD013137/urn:x-wiley:14651858:media:CD013137:CD013137-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013137.pub2/media/CDSR/CD013137/image_t/tCD013137-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Early post‐surgery imaging vs no early imaging, Outcome 2 Overall survival (deaths at 2 years)." data-id="CD013137-fig-0003" src="/cdsr/doi/10.1002/14651858.CD013137.pub2/media/CDSR/CD013137/image_n/nCD013137-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Early post‐surgery imaging vs no early imaging, Outcome 2 Overall survival (deaths at 2 years). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013137.pub2/references#CD013137-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013137.pub2/media/CDSR/CD013137/image_n/nCD013137-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD013137-tbl-0001"> <div class="table-heading"><span class="table-title"></span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Early post‐operative MRI compared with no early post‐operative MRI for glioblastoma</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Patient or population:</b> adults with glioblastoma </p> <p><b>Settings:</b> tertiary care </p> <p><b>Intervention:</b> early post‐operative MRI (within 48 hours of tumour resection) </p> <p><b>Comparison:</b> no early post‐operative MRI </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>No early MRI</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Early MRI</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Overall survival (deaths at 1 year)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>554 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>476 per 1000</b><br/> (338 to 670) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(RR 0.86, 95% CI 0.61 to 1.21)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>125 (1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>very low<sup>1</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Overall survival (deaths at 2 years)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>804 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>852 per 1000</b><br/> (732 to 1000) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(RR 1.06, 95% CI 0.91 to 1.25)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>125 (1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>very low<sup>1</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Progression free survival</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="5" rowspan="1" valign=""> <p>no evidence</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Anxiety</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="5" rowspan="1" valign=""> <p>no evidence</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Quality of life</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="5" rowspan="1" valign=""> <p>no evidence</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> is the risk in the control group of the included study. The <b>corresponding risk</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High certainty:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate certainty:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low certainty:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low certainty:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>1</sup>Downgraded for risk of bias, as the patients in this study received the interventions based on surgeons' preferences and discretion </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-title"></span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013137.pub2/full#CD013137-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD013137-tbl-0002"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">National Institute for Health and Clinical Excellence (NICE) guidance on interval imaging</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Tumour grade</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Years after end of treatment</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>0 to 1</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>1 to 2</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>2 to 3</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>3 to 4</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>5 to 10</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>&gt; 10 (for the rest of life)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Grade 1</p> </td> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p>Scan at 12 months, then:</p> <p> <ul id="CD013137-list-0001"> <li> <p>consider discharge if no tumour visible on imaging unless completely resected pilocytic astrocytoma </p> </li> <li> <p>consider ongoing imaging at increasing intervals for 15 years for completely resected pilocytic astrocytoma </p> </li> <li> <p>consider if ongoing imaging is needed at a rate of once every 1 to 3 years for the rest of the person's life if the tumour is visible on imaging </p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Grade II 1p/19q non‐codeleted, IDH mutated</p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="3" valign="top"> <p>Scan at 3 months, then every 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="3" valign="top"> <p>Annually</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>Every 1 to 2 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>Consider ongoing imaging every 1 to 2 years</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Grade II 1p/19q codeleted</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Grade III 1p/19q codeleted</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Grade II IDH wildtype</p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="3" valign="top"> <p>Every 3 to</p> <p>6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="3" valign="top"> <p>Every 6 to</p> <p>12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>Annually</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>Consider ongoing imaging</p> <p>every 1 to 2 years</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Grade III 1p/19q non‐codeleted</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Grade IV (glioblastoma)</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p>From <a href="./references#CD013137-bbs2-0078" title="National Institute for Health and Clinical Excellence. Brain tumours (primary) and brain metastases in adults. www.nice.org.uk/guidance/ng99. NICE, (accessed 08 August 2018). ">NICE 2018</a> (p17) Table 3: Possible regular clinical review schedule for people with glioma depending on grade of tumour </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">National Institute for Health and Clinical Excellence (NICE) guidance on interval imaging</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013137.pub2/full#CD013137-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD013137-tbl-0003"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Early post‐surgery imaging vs no early imaging</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Overall survival (deaths at 1 year) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 HGG</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>125</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.86 [0.61, 1.21]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 LGG</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Overall survival (deaths at 2 years) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 HGG</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>125</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.06 [0.91, 1.25]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 LGG</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Early post‐surgery imaging vs no early imaging</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013137.pub2/references#CD013137-tbl-0003">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD013137.pub2&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD013137-note-0003">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD013137-note-0009">فارسی</a> </li> <li class="section-language"> <a class="" href="ms#CD013137-note-0005">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD013137-note-0004">简体中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738735355000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738735355000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774074000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774074000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013137\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD013137\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013137\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD013137\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013137\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD013137\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013137\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD013137\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013137\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD013137\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013137\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD013137\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013137\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD013137\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013137\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD013137\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013137\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD013137\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=6XSHdtL3&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD013137.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD013137.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD013137.pub2/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD013137.pub2/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD013137.pub2%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"/> <span class="taglib-text hide-accessible">Sign In</span> </span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740720334384"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD013137.pub2/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"/> <span class="taglib-text hide-accessible">Sign In</span> </span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740720334387"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD013137.pub2/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918dfea458ac9377',t:'MTc0MDcyMDMzNC4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 